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ABSTRACT
In the present project the use of ammoniation and fermentation as an 
integrated process was studied in order to give aflatoxin-contaminated com an 
alternative use. Aflatoxin-contaminated com can be fermented to obtain fuel alcohol 
and decontaminated distiller’s dried solid grains (DDSG) can be used for animal 
feed.
The efficacy of a fermentation process, with the inclusion of ammonium 
persulfate, for the decontamination o f  aflatoxin Bi-contaminated yellow com was 
studied, as well as the effect of peroxides on the ethanol production. Addition of 
2.0% ammonium persulfate decreased the aflatoxin Bi levels by 87%. Peroxides did 
not have an effect on ethanol production. This process was not mutagenic in the 
Ames test using Salmonella tester strains TA98 and TA100 with metabolic 
activation.
An isolation procedure based on thin layer chromatography technique was 
used to isolate factors that interfered with the mutagenic potential of AFBi. A dose- 
response type of relationship between a constant dose o f AFBi and different 
concentrations of com and com fraction extracts were found in the Ames test. The 
com fractions were found not to be toxic to either, Salmonella tester strain TA98 or 
TA100.
Anti-mutagenic fractions isolated from com were tested against l-methyl-3- 
nitro-l-nitrosoguanidine (MNNG) to determine their activity on a direct acting 
mutagen. All com fractions tested positive against MNNG in the Ames test using
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Salmonella tester strain TA100. Anti-mutagenic activity was tested in five different 
varieties of com fractions. A dose-response effect was observed for all the com 
fractions tested using two tester strains with S9. Four anti-mutagenic isolates were 
analyzed by MALDI-MS and GC-MS. MALDI-MS showed the presence o f two 
groups o f molecules or molecular fragments. The molecular mass of one group 
ranged from 250 to 370 m/z, the other ranged from 540 to 640 m/z. GC-MS showed 
the presence of a linoleic acid-like compound.
The use of ammonium persulfate was shown to efficiently decontaminate 
AFBi-contaminated com during fermentation without affecting ethanol production. 
This research also found that com has a number o f compounds that may offer a 
protective effect against mutagenic events. One of these compounds may be linoleic 
acid or a linoleic acid-like compound.
xviii
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CHAPTER 1. INTRODUCTION
Aflatoxins are a group o f unavoidable contaminants o f food and feeds. These 
natural toxins are secondary metabolites of Aspergillus jlavus and A. parasiticus that 
represent a problem of major concern all over the world (Wood, 1992). These molds 
are widespread causing significant problems especially during severe periods of 
drought and plant stress, factors that trigger aflatoxins production (Phillips et al.,
1994) Contamination o f several commodities such as com, peanuts, and cottonseed 
commonly occurs before, during and after harvest. Improper storage conditions such 
as high temperature and humidity, allow spores to develop and subsequently 
produce aflatoxins (Busby and Wogan, 1984). Even though prevention is considered 
the best approach to decrease aflatoxin contamination o f commodities, several 
strategies for aflatoxin reduction exist. Procedures that involve thermal inactivation, 
irradiation, solvent extraction and mechanical separation, density segregation, 
adsorption, ammoniation, oxidation, etc., have been developed with different levels 
o f success (Phillips et al., 1994).
At the present time, 18 types o f aflatoxin have been identified, o f which, 
aflatoxin Bi (AFBi) has been implicated as a factor in human primary liver cancer, 
and classified as a probable human carcinogen (IARC, 1987). Human hepatocellular 
carcinoma has been highly related to the consumption of highly aflatoxin- 
contaminated commodities (Sibanda et al., 1997). Mutagenicity o f AFBi is well 
documented (Bailey, 1994); AFBi reacts in vivo with the DNA in target cells to give 
primarily trans-8,9-dihydro-8-(N7-guanyl)-9-hydroxyaflatoxin Bi.
1
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However, no reports on the mutagenicity of aflatoxin contaminated com was 
found. External factors, such as, decontamination treatments and aflatoxin degrading 
fungi metabolites; and intrinsic factors, such as, fungi resistant com varieties and 
chemoprotective components o f com, may affect the mutagenic potential o f aflatoxin 
contaminated com. The existence o f materials in com and cottonseed that interfere 
with the mutagenic potential of AFBi has been suggested (Lee et al., 1984; Lawlor et 
al., 1985; Haworth et al., 1989; Weng et al., 1997). However, these factors are still 
unidentified.
The present project has as a general objective o f studying the effect of 
extrinsic and intrinsic factors that may affect the mutagenic potential o f AFBj- 
contaminated com. More specifically, this project focused on: (1) the effect of 
ammonium persulfate and three different peroxides on the AFBi levels o f 
contaminated com and the ethanol production during a fermentation process, (2) the 
isolation o f the unknown interfering material previously reported to be present in 
com, and (3) the partial characterization of these anti-aflatoxin factors.
2
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CHAPTER 2. LITERATURE REVIEW
I.- Aflatoxins
1.- Discovery and Occurrence.
Aflatoxins, a group of secondary metabolites produced by Aspergillus flavus 
and A. parasiticus, are common worldwide contaminants o f food and feed (Jelinek et 
al., 1989). Aflatoxins were discovered in the 1960's when a acute hepatotoxic disease, 
caused by a etiological unknown agent, killed more than 100,000 turkeys in England. 
This disease, called Turkey "X" disease, also affected chickens and ducklings causing 
the same characteristic symptoms (Blount, 1961). A common factor in these outbreaks 
was the presence of Brazilian groundnut (peanut) meal as an ingredient (Blount, 1961). 
Toxic components in the peanut meal were extracted, isolated, characterized and finally 
named aflatoxins (Asao et al., 1963). The word aflatoxin was formed by the following 
set up, the letter "A" comes from the first letter of the genus that produces it, 
Aspergillus; the next three letter "FLA", from the species that first was known to 
produce it, flavus, and finally "TOXIN" which means poison (Ellis et al., 1991).
One o f the main reasons why aflatoxins are widely distributed is that A. flavus is 
commonly found in air and soil worldwide. A. flavus deteriorates a number of stored 
crops such as com, cottonseed, rice, barley, peanuts, soybeans, etc. During storage, this 
mold grows at relatively low moisture levels in order to avoid competition with other 
fungi such as Penicillium and Fusarium (Shibamoto and Bjeldanes, 1993). Aflatoxins 
are distributed widely throughout the world. European countries report the lowest levels 
(Trucksess, 1996, 1997). Countries in Africa such as Zimbabwe, Swaziland, Kenya,
3
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Ethiopia, Uganda, Ghana (Sibanda et al., 1997), and Nigeria (Atawodi et al., 1994; 
Sibanda et al., 1997), in Asia such as India (Trucksess, 1996, 1997), and Thailand (El- 
Nezami et al., 1995; Trucksess, 1996), and China (Shibamoto and Bjeldanes, 1993) 
have high contamination levels in a number o f diverse commodities. In Latin America, 
countries such as Mexico (Jelinek et al., 1989; Carvajal and Arroyo, 1997), Costa Rica 
(Viquez et al., 1994), Guatemala (de Campos et al., 1980), and Argentina (Jelinek et 
al., 1989) have reported to have high incidences of aflatoxins in harvested com, where 
Brazil (Jelinek et al., 1989) is the country reported to be the most affected. In the 
United States, aflatoxin is a matter of concern each year in many of the Southeastern 
states (Alabama, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, 
South Carolina and Tennessee) where the weather is favorable for the growth of A. 
flavus and A. parasiticus; however, the states with the major incidences of aflatoxins in 
com are reported to be Arkansas, Oklahoma and Texas (Wood, 1989,1992).
2.- Mode of contamination
Aflatoxins occur worldwide and Aspergillus species can grow on a number of 
substrates under diverse environments. Most foods and feeds experience a latent risk of 
invasion by aflatoxigenic strains of this mold. And, more importantly, this invasion can 
occur before or during harvest, as well as, during storage (Park and Liang, 1993). The 
most important factors that influence Aspergillus growth and aflatoxin production are 
the relative humidity found in the environment surrounding the commodity (in most 
cases (88-95%) and the temperature at which the crops are stored (25-30 C) 
(Bullerman, 1979). Aflatoxigenic fungus invade the plant, infect the seed, and finally
4
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produces the toxin in the seed. These fungi can reach the plant in a form of spore, 
mycelium, or carried by insects (Park and Liang. 1993).
3.- Chemistry and Biosynthesis
Chemically, aflatoxins are a group of bisfuran coumarin compounds of which 
the structures vary to produce different derivatives with variable activity (Pavao et al., 
1995) (Figure 2.1). The aflatoxins that produce the most severe pre- and post-harvest 
contamination of foods and feeds are aflatoxins Bj (AFBi), B2 (AFB2), Gi (AFGi), and 
G2 (AFG2), as well as Mi (AFMi) and M2 (AFM2) (Bhatnagar et al., 1994). The letters, 
in the case o f B and G, refer to their fluorescent colors (B, blue; G, green) when 
exposed to ultraviolet light; but, in the case of M, the letter refers to their presence in 
milk. The subscripts refer to their relative position on chromatographic plates.
AFBi has the highest activity and is one o f the most potent carcinogens known. 
The molecule contains a carbonyl group in a five-member ring and is cross-conjugated 
with the a ,  (i-unsaturated lactone function. The formula is C17H 12O6  (molecular weight 
= 312). The aflatoxin B2 (C17H 14O6) is the reduction product of AFBi (Pavao et al.,
1995). AFBi decomposes without melting at 268-269°C (Beuchat, 1978). Aflatoxins 
are essentially non-soluble in water and soluble in a number of non-polar solvents.
Metabolic activation (cytochrome P-450) o f AFBi to the exo -8,9-epoxide 
produces a very reactive electrophile which can bind macromolecules such as proteins 
and the N7 position of guanidine residues in DNA (Raney et al., 1993) (Figure 2.2). The 
endo epoxide has been found to be much more stable in water than the exo form and be 
non-reactive with DNA and therefore essentially non-genotoxic (Lyer et al., 1994).
5
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Figure 2.1.- Chemical structures o f aflatoxins commonly occurring in feeds and 
foods.
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Figure 2.2. Adduction of N7 position in Guanidine by aflatoxin Bi epoxide.
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Aflatoxins are secondary metabolites with apparently no obvious physiological 
role in the primary growth and metabolism of Aspergillus. Secondary metabolites are 
produced during primary metabolism and, as a consequence, factors affecting primary 
metabolism also affect secondary metabolism (Bhatnagar et al., 1991). Previous studies 
have demonstrated an association between aflatoxin and lipid biosynthesis (Gupta et al., 
1970; Shih and Martin, 1976; Townsend et al., 1984) and also a decline in protein 
synthesis during the aflatoxin-producing phase (Detroy and Hesseltine, 1970; Maggon 
et al., 1977). Studies on the biosynthesis of aflatoxin Bi have demonstrated that the 
basic skeleton of the toxin molecule is completely derived from acetate units via a 
polyketide pathway (Bhatnagar et a l,  1991). Several specific enzymatic activities have 
been shown to have a role in the biosynthesis of aflatoxins. These enzymes ( e.g., 
methyltransferases, reductases) are present in low concentrations and are very short 
lived (Dutton, 1988; Bhatanagar et al., 1991). In addition to the role of these enzymes 
in the formation of aflatoxins, the degradation of aflatoxins have been found to be 
partially due to enzymatic activity in the old or aging mycelium. There is also evidence 
that suggests the involvement of the cytochrome P-450 monooxygenase enzyme system 
in the degradation of aflatoxin Bi and Gi by intact mycelium and cell-free extracts of A. 
flavus (Hamid and Smith, 1987).
4.-Toxicity Evaluation.
Aflatoxins are unavoidable foods and feeds contaminants; therefore, the major 
route o f exposure to man and animal is through ingestion. AFBi is known to exert an 
acute toxicity to every animal studied. The LD50 values found rank from 0.36 mg/Kg
8
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for ducklings to 18 mg/Kg for chickens (Wogan, 1973; Cullen and Newbeme, 1994)). 
Toxic effects observed in humans during aflatoxicosis include jaundice, rapid 
development of ascites, portal hypertension, and gastrointestinal tract bleeding, which 
apparently is the cause of death (Palmgren and Ciegler, 1989). However, chronic 
exposure and toxigenic effects are o f more concern. AFBi is known to be a very potent 
hepatocarcinogen which requires biotransformation in order to become reactive. 
Cytochrome P-450 1A2 and 3A4 oxidize aflatoxin Bi to the reactive aflatoxin Bi-8,9- 
epoxide that accounts for its genotoxic properties (Gallagher et al., 1996).
In addition, there is also evidence that aflatoxin can be epoxidized to the 
reactive metabolite by liver lipooxygenase via lipooxygenase-mediated co-oxidation 
(Roy and Kulkami, 1997). The bioactive form of aflatoxin constitutes a strong 
electrophile which is able to form covalent adducts with macromolecules such as 
proteins, RNA and DNA (Foster et al., 1983; Miller, 1991). As previously mentioned 
aflatoxin Bi-8,9-epoxide is known to bind the N7 position o f guanine leading to the 
base substitution type of mutation in DNA (Raney et al., 1993). Another postulated 
mechanism for the cytotoxicity and carcinogenicity o f AFBi is the formation of reactive 
oxygen species during the metabolic activation of AFBi by cytochrome P450 (Shen et 
al., 1996). In addition to its mutagenic and carcinogenic properties, AFBi is also 
thought to have teratogenic activity (Miller, 1991). Even though external factors may 
alter the effect o f aflatoxins (i.e., diet, pre-existing cirrhosis, hepatitis B virus, etc.), the 
International Agency for Research on Cancer (IARC, 1987) concluded that sufficient 
evidence existed to consider AFBi as human carcinogen.
9
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Occupational Exposure to Aflatoxins
The potential role o f aflatoxins as occupational risk has been considered. 
Potential exposure to aflatoxins has been associated with primary liver cancer (PLC) in 
grain mills workers (in both, male and female) in Sweden (Mclaughlin et al., 1987). 
The inhalation of aflatoxin-contaminated dust has also been associated with the increase 
of cancer incidence in livestock feed-processing facilities in Denmark. The average 
daily intake of aflatoxin via inhalation was estimated to be approximately 170 ng of 
AFBi. The prepared mixed cattle feed was determined to contain approximately 140 
g AFB/Kg (Olsen etal., 1988).
II.- Methods o f Decontamination of Aflatoxin-contaminated Commodities
Aflatoxin contamination may be the result of fungal infestation o f crops either 
before, during and after harvest. Human exposure to aflatoxins can be through direct 
consumption of contaminated processed of unprocessed foods or indirectly by 
consuming contaminated products, such as milk, from animals that have been fed with 
contaminated feeds. Obviously, the best approach to control human and animal 
exposure to aflatoxin contamination is by prevention (Park, 1993); however, this is not 
always possible, specially before harvest. The contamination of commodities with 
aflatoxins is a problem that exists worldwide( Ellis et al., 1991), especially in grains 
which constitute the base o f the nutrition of the majority o f the world’s population. 
Therefore, due to the unavoidable and widespread contamination o f numerous 
commodities, several method of decontamination have been developed to treat affected 
foods and feeds. These decontamination methods may be physical, chemical and
10
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biological procedures that are used to minimize the risk associated with the using of 
contaminated products. Physical methods are based in principles such as mechanical 
separation, adsorption, irradiation, etc. Chemical methods involve the use of substances 
that oxidize or hydrolize aflatoxins. Biological methods involve the use of competitive 
microorganisms, plant strains resistant to fungi infestation, etc. In order for these 
procedures to be acceptable they must meet certain criteria including: (1) inactivate, 
remove or destroy the toxin, (2) not leave or produce toxic residues, (3) retain the 
commodity’s nutritive value, (4) not alter the technological properties, and (5) destroy, 
if possible, fungal spores (Park and Lee, 1990; Phillips et al., 1993).
1.- Physical Methods
In addition to the physical removal of affected grain, physical factors such as, 
heat, irradiation and adsorption have been studied for their effect on aflatoxins. Physical 
removal procedures consist of the separation of affected grains within a lot. These 
procedures have been found to be generally effective in decreasing the concentration of 
AFBi in contaminated grain lots (Brekke et al., 1975; Lopez-Garcia and Park, 1998).
Even though aflatoxin is quite stable to heat, the use o f temperature has been 
studied (Peers and Linsell, 1975). AFBi did not degrade at temperatures of 250°C; 
however it was also observed that by increasing the moisture content to 30%, AFBi was
o
reduced by approximately 85% when exposed to 100 C for 2.5 hours (Mann et al., 
1967). The use of pressure cooking and cooking with an excess of water has been found 
to destroy more of the aflatoxin in rice, providing additional evidence of the effect of 
water on the stability o f aflatoxin during heat processing (Rehana et al., 1979). The use
11
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of heat during commercial processes, such as, boiling (Adegoke et al., 1994), and 
roasting (Lee et al., 1968, 1969) have also been studied, achieving up to 70% of 
aflatoxins destruction. In general, temperatures higher than 100°C are required to result 
in partial aflatoxin degradation. The effect on nutritional and organoleptical qualities 
and the possibility o f generating toxic pyrolysates at high temperatures discourage the 
use of conventional heat processes as decontamination processes.
Studies carried out to determine the effect of irradiation on the aflatoxin content 
of commodities (Feuell, 1966; Frank and Grunewald, 1970) showed the ineffectiveness 
of this physical factor on the decontamination of commodities. It was also observed that 
the level of exposure to X-rays and electron irradiation required to destroy aflatoxins 
would also destroy the irradiated commodity. Indirect effect such as radiolysis of water 
or other food constituents may produce reactive free radicals that can lead to 
degradation o f aflatoxins but also to degradation of food components. The production 
of toxic degradation compounds of AFBi constitutes another important limitation for 
using irradiation (Samarajeewa et ah, 1990)
The use o f adsorptive clays, such as bentonite, has been found to be effective in 
the physical removal of AFBi from liquid commodities (Masimango et al., 1978; 
Phillips et al., 1994). It was observed that by adding more bentonite, more aflatoxin 
was eliminated. They also noticed that particle size and heat-treatment of bentonite 
affected its ability to adsorb and retain aflatoxin.
12
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2.- Biological Methods
The biological detoxification of aflatoxin-contaminated commodities involve 
the use of other microorganisms that have the capability of remove or transform AFBi 
to less toxic compounds. Several species of the genera Flavobacterium, Aspergillus, 
Mucor, Rhizopus, among others, have been found to either destroy or transform AFBi 
in solution (Doyle et al., 1982). Lillehoj et al., (1971) reported that Flavobacterium 
aurantiacum NRRL B-184 removed aflatoxin Mi from naturally contaminated milk. 
Molds that are capable of producing aflatoxins are also capable of degrading them. A 
number of studies showed that selected microorganisms are capable o f producing 
substances (i.e., proteins, enzymes) that degrade aflatoxins or block aflatoxin 
biosynthesis (Doyle and Marth, 1978; Cotty and Bhatnagar, 1994; Ono et al., 1997). 
However, the organism that combats aflatoxin may be the grain itself. Recent studies 
have provided evidence that com can produce proteins inhibitory to A. flavus and 
aflatoxin biosynthesis (Huang et al., 1997), and that com can be genetically 
manipulated to produce lines that show a higher resistance to fungal colonization and 
aflatoxin production (Brown et al., 1995).
Another way to reduce the toxicity of contaminated commodities is by the 
conversion of aflatoxin to a less toxic metabolite. Price et al., (1985) investigated the 
capability of dairy cattle to biotransform AFBi to AFMi (which is 10-100 fold less 
toxic than AFBi) when fed with contaminated cottonseed. They found that the federal 
action level o f 0.5 mg AFMi/L of milk would be produced by cows consuming a ration 
containing 15% whole cottonseed contaminated with approximately 250 pg AFBi/Kg.
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The average AFBi consumed:AFMi secreted in milk ratio was found to be 
approximately 1% at low levels of AFBi contamination (van Egmond, 1994).
3.- Chemical Methods
The use of chemicals to decontaminate aflatoxin-containing commodities is 
currently the most practical approach. A number of chemicals have been studied for 
their effectiveness to destroy aflatoxins and their feasibility in the treatment of diverse 
commodities. Among them are: chlorinating compounds (sodium hypochlorite, chlorine 
dioxide, and gaseous chloride), oxidizing substances (hydrogen peroxide, ozone, and 
sodium bisulfite), and hydrolytic agents (acids and alkalis) (Samarajeewa et al., 1990).
Sodium hypochlorite at concentrations of 0.25% at basic conditions effectively 
destroys aflatoxin in most of contaminated commodities. Procedures involving sodium 
hypochlorite were shown to be non-toxic in toxicity and mutagenicity tests. However, 
there is still concern about the presence of chlorine residues and the reduction of 
tryptophan content in foods (Natarajan et al., 1975). The effectiveness of gaseous 
chlorine to penetrate contaminated foods and efficiently detoxify them is still 
questionable (Samarajeewa et al., 1990).
Hydrogen peroxide in concentrations ranging from 0.5% to 6.0% have been 
shown to almost totally detoxify contaminated commodities such as, peanut protein 
isolates, com and peanut meal, without leaving toxic residues or significant detrimental 
effects on the nutritional value of treated foods (Samarajeewa et al., 1990). However, 
hydrogen peroxide residues may promote the fungal growth and aflatoxins production 
in commodities are still contaminated with fimgi. Ozone, a powerful oxidizing agent,
14
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
can reduce AFBi levels up to 91% in cottonseed meal containing 22% moisture when
o
held at 100 C for 2 hours. This prolonged time; however, decreases the available lysine 
in treated foods (Samarajeewa et al., 1990). Sodium bisulfite (1.0% and 65°C) is 
capable of reducing the AFBi content by 70% in dried figs. It has also been shown to 
be more effective than ammonia or sodium hydroxide in inactivating AFBi in com. The 
major concern of using this chemical, however, is its inability to destroy AFB2 and 
AFG2, and the possibility o f regeneration of AFBi during metabolism of treated food 
(Altuget al., 1990; Samarajeewa et al., 1990).
The relative efficiencies of different alkalis to destroy AFBi in solution at 110°C 
are: potassium hydroxide > sodium hydroxide > potassium carbonate > sodium 
carbonate > potassium bicarbonate > ammonium hydroxide > sodium bicarbonate > 
ammonium carbonate (Samarajeewa et al., 1990). The use of lime (calcium hydroxide) 
in combination with monomethylamine has been shown to reduce aflatoxin levels in 
peanut meal by 94 -100% (Park et al., 1981) Alkaline treatment causes hydrolysis of 
lactone ring in AFBi. However, there is evidence to suggest that the hydrolyzed lactone 
ring can close again under acidic conditions and regenerate AFBi. Limited information 
regarding the effect of alkaline treatments on the nutritional value o f foods is available. 
However, toxicity analyses on food treated with monomethylamine:Ca(OH)2  showed a 
decrease in toxicity compared to AFBi (Park et al., 1981). Ammonia, a extensively 
studied chemical for the detoxification of aflatoxin contaminated commodities, will be 
reviewed later in the chapter. Treatment o f AFBi with acid hydrates the molecule to 
form AFB2a which has a toxic activity 200 times less than AFBi (Lillehoj and Ciegler,
15
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1969). Because the use of strong acids may affect food quality and still produces 
AFB2a, which still has toxicity, this practice has been discouraged (Samarajeewa et al., 
1990).
4.- Aflatoxin Decontamination by Ammoniation
Ammoniation is one o f the alkali treatments that has been most intensively 
studied with a number of different laboratory and field variables. The treatment of 
aflatoxin contaminated commodities is been currently practiced in several States in the 
United States of America such as Arizona, California, and Texas for cottonseed; and 
North Carolina, Texas, Alabama, and Georgia for com. Ammoniation is also used in 
Senegal, Brazil, France, South Africa, and Sudan, for decontamination of peanuts 
(Park, 1993b). Mexico is another country that allows the use o f this procedure for 
decontamination; however, because the high cost was higher than the economic 
recovery this practice has been abandoned (Carvajal and Arroyo, 1997;). Several 
countries o f  the European community import ammonia-treated peanut meal on a regular 
basis (Park and Liang, 1993).
Ammonia can be delivered or applied to the treating commodity in the form of 
gas or aqueous solution. Both are have been found to be equally effective. Ammonia 
treatment has been found to achieve levels of decontamination higher than 99% in 
several commodities without conferring toxicity to the treated material, as well as 
increasing the non-protein nitrogen content in the feeds. In addition, the permanency of 
the ammonia treatment has been demonstrated (Weng et al., 1994) where no significant 
reversibility of AFBi post-detoxification compounds, back to AFBi in an acid
16
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environment was observed. However, ammoniation can cause some detrimental effects 
on the nutritional value of the treated commodities such as, reduction in protein quality, 
a decrease in the lysine and methionine content, and an irreversible reduction in the 
degree of unsaturation in lipids (Samarajeewa et al., 1990). The success of the 
ammoniation procedure depends on a number of factors, such as the percentage of 
moisture content in the sample, pressure applied during the process, temperature used, 
time of exposure to a combination of these factors and, of course, the kind of sample 
treated.
Factors Affecting the Efficiency of Ammoniation
The first factor that affects the ammonia-decontamination process is the level of 
ammonia used. A number of studies summarized, by Samarajeewa et al., 1990 showed 
that aflatoxin levels can be decreased by more than 95% using levels o f ammonia 
ranging from 0.5% to 7.0%. Even though the more ammonia added the more 
decontamination can be achieved, the ammonia levels more commonly used rank from
0.5% to 5.0% (Phillips et al., 1994).
During early studies performed by Brekke et al. (1977), it was observed that by 
increasing the moisture of the decontamination system, higher detoxification could be 
achieved. Similar results were obtained by Mercado et al. (1991). When treating 
aflatoxin-contaminated copra with ammonium hydroxide, 89.0% of the initial aflatoxin 
was eliminated with 7.0% moisture; but, when moisture was increased to 24.0%, more 
than 97.0% aflatoxin reduction was achieved. The moisture added may provide a better 
environment for the permeation of ammonia through the contaminated sample. At the
17
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present time, moisture levels ranging from 10 to 20 % are reported to be commonly 
used (Samarajeewa et al., 1990).
The temperature and pressure applied during the ammoniation process produces 
similar effects on the efficacy o f the decontamination process with ammonia. The use 
of ambient temperature (43°C) and atmospheric pressure in combination with 2% 
ammonia and, with or without 12% moisture has been shown to decrease aflatoxin 
levels by more than 98.0% in a period of time of 15 days (Jorgensen and Price, 1981). 
However, the time required to achieved the same levels of detoxification can be 
lowered to 15-30 min. by increasing temperature (80-120°C) and pressure (35-50 psi) 
(Samarajeewa et al., 1990). Both, high pressure/high temperature (HP/HT) and ambient 
temperature/atmospheric pressure (AT/AP) processes have been approved and are 
currently used in Arizona for decontamination o f whole cottonseed. For cottonseed 
meal, only the HT/HP process has been approved (Phillips et al., 1994).
Chemistry of Aflatoxin Ammoniation
The ammoniation process is intended to chemically modify or destroy the 
aflatoxin molecule. Ammonia degradation of AFBi involves the hydrolysis of the 
lactone ring, followed by a descarboxylation to produce lower toxicity reaction 
products (Figure 2.3). Two major compounds have been identified after ammoniation; 
one with a molecular weight 286 (aflatoxin Di), and a smaller second compound of 
molecular weight 206, both with greatly decreased toxicity (Jorgensen and Price, 1981; 
Park et al., 1988). The letter Di was designated for the descarboxylation step that
18
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Figure 2.3.- Suggested chemical reactions o f the ammoniation o f aflatoxin Bi.
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produces it. If the ammoniation procedure is carried out under mild conditions, products 
from the first step in the reaction can revert back to aflatoxin Bi. Appropriate conditions 
allow the reaction to go to further steps which are irreversible (Park et al., 1988). 
Aflatoxin Di and 206 MW compound are products of the reaction between ammonia 
and pure aflatoxin Bi; however, when meal matrices are involved, the quantities of 
these compounds are found in much lower concentration (Lee and Cullulu, 1978; Park 
et al., 1984). Many other by-products of ammoniation of aflatoxin Bi are still to be 
identified and individually tested for toxicity.
III.- Evaluation of Fermentation Processes for Decontamination of Aflatoxin- 
contaminated Commodities
Methods and procedures to decontaminate aflatoxin-affected foods and feeds 
are constantly been studied and evaluated in order to optimize those already existent, or 
to obtain more efficient and safer methods. These studies intend to combine industrial 
processes with methodologies that have already been proven to decontaminate 
aflatoxin-contaminated commodities. Fermentation is a very important industrial 
process by which ethanol is obtained for a number of purposes. This process can be 
combined with the addition of chemicals in order to treat fermentable substrates that are 
contaminated with aflatoxin, obtaining in this way, ethanol and decontaminated feeds 
that might be used for animal feed. Ammoniation is a decontamination process that 
could be integrated in a fermentation process in order to fuel alcohol from low-cost 
aflatoxin-contaminated com. At the same time, decontaminated com residue could be 
used for animal feed.
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1.- Fuel-Alcohol Production
The fuel ethanol industry has adopted a wide range of technologies in order to 
reduce cost at the different stages of the processes. Adoption of innovations and 
modifications of the current processes have occurred during the last 5 years in order to 
meet the demands resulting form the Clean Air Act stipulations for cleaner burning fuel 
(Hohmann and Rendleman, 1993). In addition, the continuous rising of petroleum costs 
and the dependence on fossil fuel sources in North America has promoted the 
investigation of methodologies to obtain ethanol from renewable resources and use this 
ethanol in blends with regular gasoline for automobiles (Nofsinger and Bothast, 1981).
The use o f ethanol as a fuel for automobiles in the United States grew from 
being insignificant in 1977 to production of 900 million gallons in 1991. New 
technologies have been combined and added to the production of ethanol from 
domestic sources, com among them. This made ethanol production cost fall and this 
was responsible for wider acceptance of alcohol as fuel. In 1981, 120,00 BTU (British 
Thermal Units) were required to produce a gallon of ethanol; at the present time, less 
than 43,000 BTU are needed for the same purpose. The use of improved enzymes and 
yeast strains have lowered the total production costs from $1.35 -1.45 per gallon in 
1980 to less than $1.25 per gallon in 1992 (Hohmann and Rendleman, 1993). 
Conversion of Corn into Ethanol
Ethanol is produced from com by two standard processes: wet- and dry-milling 
(Figure 2.4). In 1993, wet-milling accounted for about 60% of the total ethanol 
production. Dry-milling offers a less expensive method to produce high yields of
21
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Figure 2.4.- Flow charts o f wet- and dry-mill fermentation procedures.
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ethanol (2.6 gallons per bushel vs. 2.5 for wet-milling), however, the value of the 
resultant by-products is less.
In both processes, the initial steps required cleaning of the com. In wet-milling, 
com must be separated into its components by steeping it in water and sulfur dioxide in 
order to separate the germ and hull fiber. Then, germ is removed from the kernel, and 
com oil, can be extracted from the germ. From the remaining germ, com gluten meal is 
obtained. In dry-milling, the process is more simple. The milling step consists o f 
grinding the com and adding water in order to form the mash. In wet-milling, only the 
starch is fermented, unlike dry-milling in which the entire mash is subjected to 
fermentation (Hohmann and Rendleman, 1993).
In dry-milling, the mash, still containing all the feed co-products, is cooked, and 
a first enzyme {Bacillus licheniformis derived endoamylase) is added. Bacterial derived 
a-amylases are “liquefying” enzymes with high thermal stability. B. licheniformis 
derived endoamylase can tolerate temperatures of 105C. For maximum heat stability, 
calcium must be present. The role of this enzyme in the dry-milling fermentation 
process is to liquefy a gelatinized starch slurry which is produced after the cooking of 
the ground com. Bacterial endoamylase hydrolyzes 1-4 linkages o f starch causing a 
reduction in the length of large molecules chains. However, this enzyme can not break 
1-6 bonds o f amylopectin nor 1-4 linkages o f maltose. For this purpose, a second 
enzyme is required (VanCauwenberge et al., 1982; Harwood-Blanchard, 1992).
In both, dry- and wet-milling fermentation procedures, a second enzyme is 
added to convert the starch, dextrins, and maltose into glucose. This process is called
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saccharification. This enzyme is usually derived from a strain of the mold Aspergillus 
niger. Fungal glucoamylase is essentially a glucose-forming enzyme and acts by 
breaking starch and starch breakdown products into glucose units from the non­
reducing end. This enzyme can act on 1-4 and 1-6 linkages; however, it breaks the latter 
in a slower rate (Harwood-Blanchard, 1992).
The next and last step in both processes is the conversion (or fermentation) of 
glucose into ethanol by yeast, for which, temperature must be lowered to approximately 
32°C before yeast can be added. Yeast converts glucose into ethanol, carbon dioxide 
and small amounts of other organic compounds and stops when the ethanol 
concentration reaches approximately 12%.
2.- Effect of Chemicals on Ethanol Production
The high costs of the production of ethanol fuel, has made the ethanol industry, 
to focus in new technologies that may be able to lower their expenses by improving or 
optimizing procedures, in order to obtain higher ethanol yields. These innovations may 
involve the use of com hybrids that have shorter steeping times, the use of immobilized 
yeast on filtration membranes, producing a continuous process, the development of 
yeast strains that are tolerant to high ethanol concentrations, and also the use of 
chemicals that may, in some way, positively affect ethanol production (Hohmann and 
Rendleman, 1993).
Even though limited information was available, there are some studies that 
showed the effect of several chemicals on the ethanol production while carrying out 
fermentation of com, as well as fermentation of aflatoxin-contaminated com.
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VanCauwenberge et al., (1982), studied the effect of the treatment of com with 
different chemicals (acetic acid, ammonium hydroxide, formaldehyde, methylene 
dipropionate, propionic acid, and sulfur dioxide) on the ethanol production by 
Saccharomyces uvarum. Sulfur dioxide treated com showed the highest ethanol yields. 
Com treated with acetic and propionic acids, and ammonia, produced from 80 to 90% 
of the maximum theoretical alcohol possible. The rest o f the chemicals, actually 
decreased the alcohol yields. In other studies, it was also found that the inclusion of 
ammonia during the fermentation process of com favored the conversion of com into 
ethanol at levels higher than 80% of the maximum theoretical possible yields (Lillehoj 
andLagoda, 1979; Nofsinger and Bothast, 1981; Bothast et al., 1982).
3.-Ammoniation of Aflatoxin-contaminated Commodities During Fermentation
Increased fossil-fuel prices have triggered the search for more economic 
alternative methodologies to obtain automotive fuel from renewable sources. In the 
same way, renewable sources such as com and other agricultural commodities are 
priced according to their commercial quality. On the other hand, the worldwide 
occurrence of highly aflatoxin-contaminated commodities represents a constant 
problem that keeps the scientific community continuously searching for more economic 
and efficient methods of decontamination, or looking for the improvement of those 
already existent. The fermentation of aflatoxin-contaminated com treated and untreated 
com with ammonia is an alternative procedure that has been studied (Chu et al., 1975; 
Lillehoj et al., 1979; Nofsinger and Bothast, 1981; VanCauwenberge et al., 1982; 
Bothast et al., 1982).
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The stability of aflatoxin Bi during fermentation was studied while carrying out 
a brewing process (Chu et al., 1975). They added pure AFBi (1 and 10 pg/g) to the raw 
materials during mashing following a conventional micro-brewing process. AFBi was 
found to be stable to heat and insensitive to cooking processes, but was partially 
removed from the mash. Lillehoj and Lagoda (1979) studied the fate o f aflatoxin in 
naturally contaminated com and several chemical treatments for decontamination after 
performing an ethanol fermentation. Sodium hydroxide (pH=11.5), ammonium 
hydroxide (12%), sodium hypochlorite (2.0%), and hydrogen peroxide (12%), were 
found to decrease aflatoxin to non-detectable levels after one hour. However, little 
reduction of aflatoxin was observed during fermentation. The ethanol production has 
also been studied while fermenting ammonia treated com (Nofsinger and Bothast, 
1981). They investigated the ethanol production by Zimomonas mobilis and 
Saccharomyces uvarum during the fermentation o f aflatoxin-contaminated com 
previously treated and untreated with ammonia. They found that both organisms 
produced higher ethanol yields (Z. mobilis yields were higher than those by S. 
uvarum) when ammonia treated com was used. This was attributed to the addition o f 
nitrogen into the fermentation system. They encouraged the study of a fermentation 
process that involves the addition of ammonia for the decontamination o f aflatoxin- 
containing com.
Bothast et al. (1982) carried out this study and found that the addition o f 
ammonium hydroxide during liquefaction decreased the AFBi levels by 80 to 85%. 
They also confirmed that the addition of ammonia caused better ethanol yields with
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distillers yeast. As previously mentioned, VanCauwenberge et al., (1982), also found 
that pre-treatment of com with ammonia allows very high (80-90%) ethanol yields 
compared to the maximum theoretical possible. From this information the continuation 
of the study of ammoniation of aflatoxin-contaminated com and ethanol production as 
an integrated process is encouraged.
IV.- Safety Evaluation of Decontamination Processes
As previously mentioned, the decontamination of aflatoxin-containing foods 
and feeds has been studied and performed using physical, biological, and chemical 
procedures. However, if a decontamination procedure is not proven to be safe, or at 
least, to produce a food or feed which consumption represents a risk that falls within an 
acceptable range, it can not be used. Therefore, every procedure must be exhaustively 
tested for its toxicity potential, including acute, sub-chronic, and chronic effects, before 
it can be approved by regulatory agencies. Several biological assays have been 
developed to test toxic, mutagenic, teratogenic, and carcinogenic potential.
1.- Safety Evaluation of Ammoniation
Chemical analysis on ammoniated aflatoxin-contaminated products have 
showed that the mycotoxin is reduced or changed as a consequence of the ammonia 
treatments. Studies for the evaluation of the safety of the ammoniation protocols can 
be classified in two categories: (1) whole animal feeding studies, where animals are 
exposed via oral administration to the ammoniated aflatoxin-contaminated feeds, and 
(2) studies where the toxicological properties o f totally or partially isolated
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ammonia/aflatoxin reaction related products resulting form ammoniation of 
contaminated commodities (Park et al., 1988).
Acute and chronic toxicity studies carried out on ducklings, turkeys, rats, 
mice, swine, chickens, trout, and dairy and beef cattle, have shown that, in general, 
ammoniated aflatoxin-contaminated feeds are much less toxic than untreated 
aflatoxin-contaminated feeds. Animals fed with untreated feeds showed extremely 
toxic events ranging from liver neoplasia to death in short time. On the contrary, 
when aflatoxin-contaminated feeds treated with ammonia were used, minor signs of 
toxicity, such as reduction in protein efficiency ratio (PER) in ducklings, slight 
increase in organs weight (liver, kidneys) in rats, and lack of signs in rainbow trout 
(a very sensitive animal model for aflatoxin) (Park et al., 1988).
However, the use of feeding studies on preliminary evaluation of the safety of 
ammoniation procedures is very expensive. The use of in vitro studies such as the 
Salmonella/mammalian microsomal mutagenicity test, the Ames test (Maron and 
Ames, 1983), brine shrimp toxicity assay (Draughton and Childs, 1982), has become 
a common practice for the safety evaluation, not only ammoniation procedures, but 
also for other protocols.
2.- Determination of the Mutagenic Potential of Ammoniated Commodities 
Using the SalmonellalMicrosomal Mutagenicity Assay (Ames Test)
With the isolation and identification o f aflatoxin-ammonia reaction products, 
a number of studies were carried out to analyze their potential toxicity compared to 
that o f AFBi using various types of bioassays, such as chicken embryo, LF- 
spontaneous hepatoma cell culture, brine shrimp, and bacterial (Bacillus megaterium
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and B. subtilis\ Salmonella typhimurium), among others (Park et al., 1988). AFBi 
mutagenic activity is started by a biotransformation of the parent compound into a 
reactive metabolite by microsomal activation of the mixed function oxidase system 
(cytochrome P450 isozymes).
The possible mechanism by which bioactivated aflatoxin Bi (aflatoxin B |- 
8,9-epoxide) may cause mutagenesis by initiating a AFBi-DNA binding process 
which causes single-strand gaps that may result in the inhibition of DNA polymerase 
activity at DNA binding sites. This event may stimulate an error-prone repair system 
that may induce mutations either by the insertion o f erroneous nucleotides or through 
errors during filling of single-stranded gaps that do not contain additional DNA 
lesions (Ellis et al., 1991). Base on this, the development o f mutant bacterial strains, 
susceptible to the attack of bioactive compounds, has been possible and used to test 
the mutagenic potential o f a variety of either pure compounds or complex samples.
The Ames test, which involves the use o f mutant tester strains of Salmonella 
typhimurium, has been widely used to determine the mutagenic potential o f 
aflatoxin-ammonia reaction products resulting form the treatment o f contaminated 
commodities. Studies carried out on extracted fractions from the ammoniation of 
aflatoxin-contaminated cottonseed meal were tested for mutagenicity using the Ames 
test. It was observed that in methylene chloride fractions (were AFBi was extracted) 
were positive for both non-ammoniated and ammoniated meal; however, 
approximately 180 mg of these extracts were necessary to produce the same 
mutagenicity o f 0.005 mg of AFBi (Lee et al., 1983; Lawlor et al., 1985). In an other
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study, Draughton and Childs (1982) treated pure AFBi with ammonium hydroxide 
and autoclaved for 10 min at 15 psi (121C). They found no additional mutagenic 
potential when the decontamination reaction products were combine with pure AFBi. 
More recently, yellow com was treated with ammonia (Weng et al., 1994) at 
different conditions. The distribution o f  aflatoxin-ammonia reaction products in the 
com  was determined (Martinez et al., 1994) and the different fractions were 
analyzed for mutagenicity using the Ames test (Weng et al., 1997). None of the 
fractions showed mutagenic activity.
The Ames test is a relatively easy-to-perform method that, because of its 
availability and reliability to detect known animal carcinogens and bacterial 
mutagens, has become a very useful tool in the safety evaluation o f different 
treatments applied to foods and feeds. However, it is very important to take into 
account that the use o f mutagenicity tests to predict carcinogenesis, is not perfect. 
Maron and Ames (1983), while making a review of this method, indicated that 
correlation between carcinogenicity and mutagenicity was 83%. Known carcinogenic 
compounds such as polychlorinated pesticides have tested negative in the Ames test 
(Ames and McCann, 1981).
In principle, the Ames test consists o f exposing one o f more Salmonella 
typhimurium mutant (converted to histidine dependent) strains to the potential 
mutagen or sample. Either with or without metabolic activation, the tested sample or 
compound will revert the bacteria from histidine-dependent to histidine-independent
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which will be able to grow on a histidine deficient media and counted after 48 hr o f 
incubation at 37 C.
Tester Strains
A set o f histidine-requiring strains is used for mutagenicity testing. Each 
tester strain contains a different mutation in the operon coding for histidine 
biosynthesis. Tester strains TA97, TA98, TA100, and TA102 contain a mutation (rfa 
mutation) that makes the lipopolysaccharide barrier coating the surface o f the 
bacteria more permeable to larger molecules, therefore enhancing the penetrability of 
potential mutagens (Ames et ah, 1973a). Another mutation present in these tester 
strains (except TA102) is the uvrB mutation. This mutation is a deletion of the gene 
coding for the excision repair system, which causes a permanency of the effect o f the 
mutagens; therefore, increases the sensitivity of the strains (Ames et al., 1973). This 
mutation is found in the gene coding for biotin synthesis; as a consequence, these 
bacteria also require administration of biotin to grow. In order to increase their 
sensitivity, these tester strains contain a R-factor plasmid pKM lOl, which enhances 
and error-prone DNA repair system and increases the chemical and spontaneous 
reversion rate o f the strains (McCann etal., 1975; Levin et al., 1982).
The histidine mutation in TAIOO is found in the sequence coding for the first 
enzyme in the histidine biosynthesis pathway. This mutation substitutes GC, GC, GC 
(histidine independent) for GC, AT, GC (histidine dependent) (Bames et al., 1982). 
As a consequence, TA100 tester strain detects mutagens that cause a base-pair 
substitution type of mutation which restore the right sequence for production of
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histidine. The histidine mutation in TA98, which is found in a sequence coding for 
histidinol dehydrogenase, consists o f a shifted pairing that occurs in repetitive 
sequence or "hot spots" (in this case, repetitive GC). This strain detects various 
mutagens that cause ffameshift type of mutation that restores the right sequence for 
histidine biosynthesis (Isono and Youmo, 1974).
Maron and Ames (1983) recommend confirming tester strain genotypes when 
bacteria have been received, when a new frozen or lyophilized permanent is been 
opened, right before performing a mutagenicity test, when spontaneous revertants 
fall out o f normal range, or when the sensitivity to standard mutagens has become 
weaken or lost. For this purpose, there is a set o f biochemical tests that can be 
performed; confirmation of histidine requirement by growing bacteria in selective 
agar, testing of UV light sensitivity (uvrB mutation), sensitivity to grow in a crystal 
violet containing agar (rfa mutation), and testing the resistance to antibiotics 
(ampicillin for TA98 and TA100, and tetracycline for TA102) present in media (R- 
factor). All tester strains were originally derived from Salmonella typhimurium LT2. 
Although, TA98 and TA100 are the most commonly used tester strains to test 
aflatoxin-induced mutagenicity (Droughton and Childs, 1982; Lawlor et al., 1985; 
Jorgensen et al., 1990; Balanski, 1992; Decoudu et al., 1992; Rojanapo and 
Tepsuwan, 1993;Weng et al., 1997), Salmonella tester strains TA98, TA100, and 
TA102 are recommended for general mutagenesis testing (Maron and Ames, 1983).
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Spontaneous Reversion
The number o f spontaneous (natural) revertants from histidine dependent to 
histidine independent should be obtained routinely in every mutagenensis experiment 
and expressed as the number o f natural or spontaneous revertants per plate. The rate 
of spontaneous reversion is characteristic for each tester strain. The number of 
spontaneous revertants after 48 hours o f incubation depends on the concentration of 
histidine concentration. However, spontaneous reversion is independent o f the initial 
number o f  cells plated, within a certain range (105 to 108 cells). Even though the 
number o f  natural revertants obtained from one experiment may be different to that 
obtained in others, or even within the same experiment, it is recommended to run at 
least three spontaneous revertant control plates in every experiment from each strain 
(Maron and Ames, 1983). The normal ranges for spontaneous revertants without 
metabolic activation cocktail (S9 mix) are: for TA98, 30-50/plate; TA100, 120- 
200/plate; TA102, 240-320/plate. Abnormally high spontaneous revertant numbers 
may indicate contamination or accumulation of back mutation by repeating sub- 
culturing. A decrease may indicate partial or complete loss o f the R-factor (if they 
are sensitive to ampicillin). Other factors may cause variability in the number of 
spontaneous revertants is the nutrient broth. Difco nutrient broth has been found to 
caused mutations in tester strain TA100 without metabolic activation. In general, 
nutrient broth that contains beef protein extracted at high temperatures may be 
mutagenic (Maron et al., 1981; Maron and Ames, 1983).
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Metabolic Activation (S91
Many compounds require biotransformation to reactive metabolites in order 
to acquire mutagenic activity. The S9 mix is enzymic suspension that is obtained by 
centrifuging induced-liver homogenates at 9000 xg and saving the supernatant (S9) 
by decanting it. This suspension contains several microsomal enzymes, the mixed 
function oxidase system (cytochrome P450) among them, that are responsible for the 
transformation of the parent compound into the reactive metabolite. For general 
mutagenesis experiments, it is recommended to use liver homogenates from rats that 
have been previously induced with a polychlorinated biphenyl (PCB) mixture, such 
as Aroclor 1254 (Alvares et al., 1973; Schmoldt et al., 1974). The role of Aroclor 
1254, as with any other inducer chemical, is to promote the production of metabolic 
enzymes in the exposed liver in order to achieve a higher protein (enzymes) 
concentration when preparing the S9 mix (Alvares et al., 1973). The purpose of the 
inclusion of a metabolic activating mixture in the mutagenesis assay, is to try to 
mimic the metabolic processes that the testing compound or sample would go 
through when it reaches the mammalian liver. Differences in the metabolic activity 
o f S9 preparations have been found to depend on the liver source and the inducer 
used (Ames et al., 1973b; Ames et al., 1975).
Types o f Assays
The plate incorporation procedure is the most commonly used type of assay 
(Droughton and Childs, 1982; Lawlor et al., 1985; Jorgensen et al., 1990; Balanski, 
1992; Decoudu et al., 1992; Rojanapo and Tepsuwan, 1993;Weng et al., 1997). This
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procedure consists of combining the sample or testing compound with the tester 
strain into the molten top agar, then the S9 mix (if required) is added, and then this 
mixture is poured onto a minimal glucose agar plate. After 48 hours o f incubation at 
37 C, the revertant colonies are counted. However, some mutagens are poorly 
detected in the standard plate incorporation assay; they require a more sensitive 
method. The most widely used procedure first described by Yahagi et al. (1975) 
which includes a pre-incubation o f the mutagen or sample, the S9 mix, and bacteria 
at 37°C for 20-30 min and then combined with the top agar to be poured onto the 
minimal glucose agar plate. The increase in sensitivity has been attributed to the fact 
that the test compound or sample, S9, and bacteria, are incubated at higher 
concentrations (than those occurring in the standard plate incorporation) (Prival et 
al., 1979).
Diagnostic Mutagens
For each mutagenicity test, a positive control must be included. This control 
helps to confirm the reversion properties of the tester strains and the efficacy of the 
metabolic mixture (S9). Some of the positive controls routinely used do not require 
metabolic activation: 2,4,7-trinitro-9-fluorenone, and 4-nitroquinoline-N-oxide, for 
both TA98 and TA100; also daunomycin for TA98, and sodium azide for TA100. 
Positive control that require metabolic activation are: 2-aminofluorine, N-methyl-N'- 
nitro-N-nitrosoguanidine, and benzo(a)pyrene for both tester strains.
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Compatible C arrie r Solvents
Compounds tested for mutagenicity are commonly dissolved in dimethyl 
sulfoxide (DMSO) when they are not soluble in water. In general, DMSO is the most 
useful carrier solvent because of its capability o f dissolving a wide range o f 
chemicals, it is relatively non-toxic to the bacteria, it does not affect the microsomal 
enzymes, and it is miscible in the molten top agar. However, there are compounds 
that may not be soluble or stable in DMSO (Szmant, 1971). Therefore, the potential 
of other solvents for being used as carrier solvents in this assay has been studied 
(Maron et al., 1981). Thirteen additional solvents have been evaluated for their 
compatibility with this test system, and 12 were found to be satisfactory under 
certain restrictions: glycerol formal, dimethyl formamide, formamide, acetonitrile, 
ethanol (95%), acetone, ethylene glycol, dimethyl ether, l-methyl-2-pyrrolidinone, 
p-dioxane, tetrahydrofurfuryl alcohol, and tetrahydrofuran.
V.- Anti-mutagens in Food
One of the most devastating diseases at the present time is cancer. Cancer is a 
multistage event that has been divided into three stages: initiation, promotion, and 
progression (Pitot and Dragan, 1996). Initiation, involves simple mutation 
(transitions, transversions, deletions, etc.) involving the cellular genome; in some 
species it also involves point mutations in signal transduction genes, in 
protooncogenes, and/or potential cellular oncogenes. Promotion involves reversible 
enhancement or repression of gene expression, inhibition of apoptosis, and indirect 
alteration o f DNA structure by promoting agents. Progression is a more complex
36
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
stage that involves genetic alteration, such as, chromosomal translocations, deletions, 
recombination; it also involves irreversible modification in gene expression, 
selection o f neoplastic cells for optimal growth in response to cellular environment 
and karyotypic instability (Pitot, 1993a).
Even though cancer is a disease that remains difficult to cure, it is 
preventable (Huang et al., 1994). More than 60% of human cancer cases are 
preventable depending on personal decisions. Cancer prevention in humans can be 
divided into two modes: passive and active. The passive mode involves factors, such 
as smoking cessation, dietary restrictions, moderation in alcohol intake, modification 
of sexual and reproductive habits, avoidance of excessive exposure to ultraviolet 
light, etc. Among the factors included in the active mode are the administration of 
antihormones, determination o f genetic background in relation to neoplastic diseases, 
screening for pre-neoplastic lesions, application of ultraviolet blocking agents, 
vaccination against oncogenic viruses, and modification o f diet and intake o f 
supplements (Pitot, 1993b).
Human diet includes a large number of compounds that may have some anti- 
mutagenic and/or anti-carcinogenic properties. Even though there is information that 
suggests that anti-mutagenic compounds can be present in a wide variety o f foods as 
a consequence o f chemical reactions (i.e., Maillard reaction products) (Usman and 
Hosono, 1997), a number o f animal studies show that many anti-carcinogenic and 
anti-mutagenic compounds are phytochemicals that are present in fruits and 
vegetables (Wattenberg, 1983; Boone et al., 1990; Wattenberg, 1992). The
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supplementation o f diets with either certain fruits and vegetables or some of their 
components has been found to decrease the incidence of chemically-induced tumors 
in several animal species (Wattenberg, 1992).
1.- Mechanism of Action
In studies carried out on the mechanism o f action o f various agents present in 
vegetables such as broccoli, cabbage, burdock and some juices, agents capable of 
suppressing mutagenicity events were found. It was proposed that anti-mutagenic 
agents, such as these, can be divided in two types: desmutagens and biodesmutagens 
(Kada et al, 1978; Kada, et al., 1982). Desmutagens are capable, in several ways, of 
preventing damage in cellular DNA by blocking access to potential mutagens. 
Biodesmutagens have been proposed to act while the mutagenesis processes are 
occurring by means o f enhancement of repair mechanisms and suppressing errors in 
the DNA repair processes (Figure 2.5)(Namiki, 1994).
Blocking Agents or Desmutagens
The first step in desmutagenesis is the inhibition o f the mutagen formation. 
Dietary compounds such as, a-tocopherol, ascorbic acid, cysteine, and phenolic 
compounds have been found to act against nitrosamine formation (Mergens et al., 
1980; Namiki, 1994). More recent studies have found that Maillard reaction 
products, such as, melanoidin also have anti-mutagenic properties (Usman and 
Hosono, 1997). It is postulated that melanoidin may have a role in the inhibition of 
nitrosamine formation.
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Figure 2.5.- Schematic representation of the action o f desmutagens and bio­
desmutagens during the carcinogenesis process.
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Another way in which mutagens can be blocked is by direct inactivation. 
Chemical inactivation has been observed in the case o f metabolically active 
compounds such as l-methyl-3-nitro-l-nitrosoguanidine (MNNG) and aflatoxin Bi- 
8,9-epoxide, by green and black tea(Yen and Chen, 1994; Choi and Moon, 1997), 
oolong, pouchong (Yen and Chen, 1994) extracts, Chinese radish extracts (Rojanapo 
and Tepsuwan, 1993), and hydroxy radical by Chinese herbs extracts (Cao and Zhu, 
1997). The inhibitory effect of dairy products on the mutagenicity o f direct acting 
compounds (i.e., 2-nitrofluorene) has also been tested in the Ames test (Cassand et 
al., 1994). Caffeine, which is a compound very commonly found in diet, has also 
been found to inhibit the mutagenic effects o f direct acting chemicals (Balanski, 
1992).
Enzymatic inactivation of mutagens has been demonstrated following 
fractionation and purification procedures by a heat sensitive heme-protein substance 
(Kada et al., 1982), similar to horseradish peroxidase. Fractionation and purification 
o f extracts from burdock led to a lignin-like polymer. This polymer is thought to 
complex mutagens resulting in co-excretion (Namiki, 1994). More evidence about 
physical interaction as mode of desmutagenesis was found by Gonzales de Mejia et 
al. (1997). They studied the antimutagenic properties o f lutein and xantophylls 
(pigments for poultry and human use) present in Aztec marigold against 1- 
nitropyrene. Their results suggested that the major mechanism o f action of lutein 
against 1-nitropyrene mutagenicity was the potential formation of a complex
40
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
between lutein and 1-nitropyrene, which may limit the bioavailability o f the 
mutagen.
Many compounds must be enzymatically bioactivated in the liver (Phase I 
and Phase II metabolism) or in other organs in order to be mutagenic. The inhibition 
of these processes is assumed to result in desmutagenesis (Namiki, 1994). However, 
desmutagenesis can result from selective activation or induction of lower 
microsomal catalytic capacity enzymes which will produce the mutagen but at lower 
concentrations or at slower rates. This mechanism was suggested by Takahashi et al. 
(1995) during studies of the effects of indole-3-carbinol (compound found in 
cruciferous vegetables such as cabbage, broccoli, etc.) on the mutagenicity of 
aflatoxin Bi. 3,3-diindolylmethane, the major indol-3-carbinol derivative found in 
liver, non-competitively inhibited EROD activity (ethoxyresorfurin-o-deethylase, 
liver enzymatic activity) and enzymes that catalyze aflatoxin Bi epoxidation. 
Polyunsaturated fatty acids such as, arachidonic acid and oleic acid, were found to 
inhibit the activation o f several compounds and aflatoxin Bi was one of them (Ho et 
al., 1992). Modulation of aflatoxin Bi metabolism has been suggested as a possible 
mechanism of action for the anti-mutagenic properties o f green tea (Qui et al., 1997).
Several other food components, such as isothiocyanates (cruciferous 
vegetables), allium organosulfur compounds (garlic, onions, leeks, etc.), flavonoids, 
flavonones, flavonols, and flavones (fruits, vegetables, nuts, cereals), cathechins (tea 
leaves), isoflavones (soy products), phenolic compounds (most plants), terpenoids 
(citrus fruit oils), and psoralens (celery, parsley, figs), have been found to have the
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capability of altering the levels o f phase I and phase II enzymes. Some have shown a 
selectivity on either the induction of specific metabolizing enzymes or induction of 
these enzymes in specific tissues (Smith and Yang, 1994).
Suppressing Agents or Bio-antimutagens
As previously mentioned, bio-antimutagens reduce the incidence of 
mutations in cells that have been already exposed to mutagenic agents and have 
some DNA damage. In order to identify bio-antimutagenic active compounds, there 
is a common screening test where E. coli WP2 B/r cells are exposed to X-ray, 
ultraviolet light, MNNG, or other mutagens; then, these cells are exposed to the 
testing compound (the suspected bio-antimutagen) and the frequencies o f induced 
mutations are compared (Inoue et al., 1981). Some of the compounds that have been 
found to have bio-antimutagenic activity such as, cinnamaldehyde, vainillin, and 
coumarin, have an a-p-unsaturated aldehyde structure which is thought to play a role 
as the active site or moiety. Other food components that in their structure posses a 
pyrogallol moeity, like gallic acid, epicatechin gallate, and epgallocatechin, reduced 
the mutation frequency against ultraviolet light. Molecular genetic studies on these 
compounds indicated that a repair system for DNA damage is involved (Namiki, 
1994).
2.- Anti-mutagenic Activity in Corn
In addition to the possibility that selected anti-mutagenic compounds 
described above may be present in com specific but controversial information is 
available about the presence o f factors in com that, by one way or another, are able
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to affect the mutagenic potential of either pure AFBi or AFBi-contaminated 
commodities.
Lee et al. (1984) used a model system to study the mutagenic potential of 
ammonia-related aflatoxin reaction products. Pure AFBi was radiolabeled and 
subjected to ammoniation. Based on this study Haworth et al. (1989) performed a 
mutagenesis testing on the ammonia-related reaction products previously obtained 
using Salmonella tester strain TA100 in the Ames test. They found that all the 
fractions isolated in the previous study showed some degree o f mutagenicity, but all 
were less mutagenic than pure AFBi. However these studies were carried out in a 
model system, not in contaminated commodities where the meal matrix was present. 
Haworth et al., suggested that more mutagenic activity may be observed when AFBi 
was ammoniated in a model system without meal matrix than when actual AFBi- 
contaminated meal matrix was ammoniated. The meal matrix components apparently 
influence the formation of ammoniated aflatoxin by-products and their mutagenic 
potential. In a study carried out with cottonseed meal (Lawlor et al, 1985), pure 
AFBi showed mutagenicity at 5 ng/plate in the Ames test (TA100). However, 
ammoniated cottonseed meal extracts in CH2CI2 , showed some mutagenicity; but 
again, much lower concentrations than pure AFBi and approximately 30,000 times 
less active. Weng et al. (1997), while evaluating the safety o f the ammoniation 
treatment of aflatoxin-contaminated com, performed the same mutagenesis testing 
procedures used by Lawlor et al. (1985) in the extracts obtained. No mutagenic 
activity was observed in any of the fractions obtained from com. It was suggested
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that a pretreatment with petroleum ether used by Lawlor et al., for cottonseed meal 
may had eliminated the active compounds (called "unknown interfering materials", 
Weng et al.), that would have been also extractable with CH2CI2 , allowing Lawlor et 
al. to still observe some mutagenic activity. None of the studies identified the 
"unknown interfering materials".
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CHAPTER 3. EFFECT OF AMMONIUM PERSULFATE, 
AZODICARBONAJVHDE, BENZOYL PEROXIDE, AND HYDROGEN 
PEROXIDE ON THE AFLATOXIN CONTENT AND ETHANOL 
PRODUCTION AFTER FERMENTATION OF AFLATOXIN- 
CONTAMINATED CORN.
I.- Rationale
In order to give an alternative use to aflatoxin-contaminated com, the 
detoxification of AFB,-contaminated com in an ammoniation-fermentation integrated 
process was studied. This process could be used for the production of fuel ethanol from 
aflatoxin affected com. Different concentrations (0.25, 0.50, 0.75, 1.00, 1.5, and 2.0% 
w/w) of ammonium persulfate were tested for their capability of detoxifying AFB,- 
contaminated com during fermentation. In order to increase the ethanol production 
during fermentation and detoxification o f com, 0.5 and 1.0 % (v/w) of either, 
azodicarbonamide, benzoyl peroxide, and hydrogen peroxide were tested. Peroxides 
were added at three different stages of the fermentation process: liquefaction, 
saccharification, and fermentation. Levels of AFB,and ethanol were determined after 
every fermentation process. The greater level of detoxification was obtained after the 
addition of 2.0% ammonium persulfate without any effect on the ethanol production. 
The addition o f peroxides did not significantly (P < 0.05) increase ethanol production 
and it did not significantly (P < 0.05) improve the detoxification of com. The best 
process for detoxification of com included the addition of 2.0% ammonium persulfate 
and 1.0% banzoyl peroxide. The best process for ethanol production included the 
addition of 2.0% ammonium persulfate and 0.5% benzoyl peroxide.
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II.- Introduction
Aflatoxins are unavoidable food and feed contaminants the may reach the 
commodities before, during, and after harvest. Every year, large amounts of crops are 
contaminated with aflatoxins. However, the discontinuation of the feeding of aflatoxin- 
contaminated com is not always practical; especially when alternative feed is not 
available (Phillips et al., 1994). Therefore, alternative uses for the aflatoxin affected 
commodities have to be developed. Very successful decontamination procedures have 
been developed. These procedures include thermal inactivation, mechanical separation, 
density segregation, adsorption, ammoniation, etc.
Ammoniation has been proven to be one of the most successful methods of 
decontamination for aflatoxin-contaminated commodities. The ammoniation process 
using ammonium hydroxide or gaseous ammonia has been demonstrated to reduce levels 
o f aflatoxin by 99 % in a number of commodities (Phillips et al., 1994). One of the uses 
that have been for ammoniated com is the ethanol production (Lillehoj and Lagoda, 
1979; Nofsinger and Bothast, 1981; Bothast et al., 1982; VanCauwenberge et al., 1982). 
During these studies, aflatoxin reduction superior to 90 % was achieved. It was also 
found that ammoniation of com did not affect the ethanol production. These findings 
suggest the possibility of producing fuel alcohol from aflatoxin affected com.
Due to the high costs that are involved in the production of fuel ethanol, new 
techniques are constantly being developed to minimize expenses (Hohmann and
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with ammonia during this process would offer decontaminated com that can be used as 
animal feed. The present study, the first part o f this project, involved the evaluation of 
the decontamination of aflatoxin-containing com with ammonium persulfate during a 
fermentation process. In addition, the effect of three peroxides on the ethanol production 
and the levels o f  aflatoxin B, was also tested.
III.- Materials and Methods
1.- Chemicals
Bacillus licheniformes derived thermostable endoamylase (Maxaliq, IBIS, 
Charlotte, NC), Aspergillus niger derived amyloglucosidase (Amigase, IBIS, Charlotte, 
NC), ammonium persulfate, ammonium sulfate, celite, calcium chloride, ammonium 
hydroxide, glucose, and sodium hydroxide, hydrogen peroxide, azodicarbonamide, and 
benzyl peroxide (Sigma Co., St. Louis, MO), methanol, chloroform, hexane, ethylic 
ether, ethanol, acetonitrile and hydrogen chloride (Mallinckrodt Baker, Inc., Paris, 
Kentucky), solid phase C-18 extraction columns (Varian, Harbor City, CA) were 
purchased and prepared as appropriate. Brewing yeast (DORIC® dry distillers yeast) was 
purchased a from local grocery store (Tucson, AZ).
2.- Corn Sample Preparation
Naturally aflatoxin-contaminated yellow com, originated from Arizona, was 
ground in a Wiley mill to pass a 20 mesh screen, then homogenized in a tumble blender 
for 30 min. The ground com was packed in plastic bags, labeled and stored at 4°C until 
further analysis and experimentation.
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3.- Fermentation Process Using Ammonium Persulfate
The fermentation process consisted o f three steps: liquefaction, saccharification 
and fermentation (Figure 3.1).
Liquefaction.- One-hundred grams of com, 30 mg of calcium chloride, 0.0, 0.5,1.0, 1.5, 
and 2.0% (w/w) of ammonium persulfate, and 400 raL o f distilled water were combined 
in a 1000 mL Erlenmeyer flask. Subsequently, the pH of the mixture was adjusted to 6.2 
using 1.0 N HC1 or 1.0 N NaOH, and 0.3 mL of Bacillus licheniformis derived endo-a- 
amylase were added. Erlenmeyer flasks, containing this mixture, were capped with 
cotton and foil and cooked at 105°C for 5 minutes. After autoclaving, the flasks were put 
into a 90°C water bath for 2 hours with continuous agitation provided by magnets and 
stirring plates.
Saccharification.- The mash was cooled by adding 100 mL of distilled water. The pH 
of the mash was adjusted to 4.2 using either 1.0 N HCL or 1.0 N NaOH, and 0.3 mL of 
amyloglucosidase was added to this mixture. The flasks were then put into a 60°C water 
bath for 2 h with continuous agitation, as described above.
Fermentation.- In order to set the fermentation stage, the yeast (Saccharomyces 
cereviceae) suspension was prepared in advance. The contents of the commercially 
available DORIC dry distillers yeast package were suspended in 10% (w/v) sugar 
(glucose) water at 40°C gently agitating with a glass stirring rod to assure yeast 
reconstitution. The yeast suspension was allowed to stand for 5 minutes. A visual sign of 
the yeast activity was the development of abundant foam. Once the yeast suspension was 
ready, the temperature of the mash was lowered to approximately 40°C and the pH
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Figure 3.1.- Flow diagram of the fermentation process
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was adjusted to 4.5. Five milliliters of the yeast suspension was added to the mash. The 
flasks were capped with single hole rubber stoppers and covered with parafilm to avoid 
any gas leakage. Through the stopper's hole, a glass tube was introduced to the flask in 
order to allow passage of gas, produced by the yeast, to a test tube containing water. The 
production o f  bubbles in the test tubes indicates the ongoing fermentation process inside 
the flask. The inoculated mixture was held at 30°C for 72 h. After 72 h, the contents of 
the flask were placed in plastic bags, stored at -20°C and freeze-dried for further 
aflatoxin analyses.
4.- Fermentation Procedure Using Ammonium Persulfate and Peroxides
The fermentation process was carried out almost exactly as described above with 
the following modifications as indicated in Figure 3.2.
Two concentrations (0.5 and 1.0%) of the three different chemicals, 30% 
hydrogen peroxide solution, azodicarbonamide, and benzyl peroxide, were added at 
different stages o f  the fermentation process: liquefaction, saccharification, and 
fermentation. During liquefaction, 2.5 grams or 5.0 grams of azodicarbonamide or 
benzyl peroxide, or 2.5 mL or 5.0 mL in the case of hydrogen peroxide, were added right 
before adjusting the pH of the mesh to 6.2, then bacterial (Bacillus licheniformis) 
endoamylase was added and the process continue as previously described. During 
saccharification, the same amount of peroxides were added after the addition of 100 mL 
of distilled water (cooling down of the mesh) and right before adjusting the pH of the 
mesh to 4.2, then fungal (Asperigillus niger) amyloglucosidase was added and the 
process continued. Finally, during the fermentation stage, the peroxides were added
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Figure 3.2 Flow diagram of the fermentation process indicating the steps where the 
peroxides were added.
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when the temparature of the mesh was lowered to approximately 40°C, then the pH was 
adjusted to 4.5 and the yeast (Saccharomyces cereviceae) was added. In all of the cases, 
the fermentation was set at 30°C for 72 h. At the end of the fermentation period, 4.0 mL 
samples o f the supernatant were taken and frozen at -4°C for further ethanol 
determination.
5.- Aflatoxin Determination
Original clean com, original aflatoxin-contaminated com and distillers dried 
grains were analyzed according to the method described by Thean et al. (1980). 
Extraction.- Fifty grams of ground com were combined with 200 mL of a methanol- 
water (80:20 v/v) solution and 5.0 grams of celite and blended for 3 minutes at high 
speed. After blending, the extract was filtered through Whatman No. 2 filter paper using 
a 9.0 cm Buchner under vacuum. From the filtrate, a 100 mL aliqout was collected. 
Filtrate clean up.- From the 100 mL aliqout, 75 mL were separated and combined with 
75 mL of 0.61 M ammonium sulfate solution and 5.0 grams o f celite, then stirred 2 
minutes with the aid of a magnet and stirring plate. After agitation, the mixture was 
filtered through Whatman No. 2 filter paper. Then, 100 mL of the filtrate were 
transferred to a 250 mL separatory funnel and 5 mL of chloroform were added and the 
mixture was vigorously shaken for 2 minutes. The chloroform fraction (lower phase) was 
drained (approximately 3.5 mL) into disposable 20 mL scintillation vials. Again, another 
volume of 5.0 mL of chloroform was added and the shaking process was repeated. 
Approximately 5.0 mL of the lower phase were drained and mixed with the first drained 
volume of chloroform. This extract was dried under nitrogen stream.
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Extract clean up (use of affinity columns).- In order to clean the extract, commercially 
available Varian C-18 solid phase extraction columns were used. The column was wet 
with 3 mL of hexane. The extract was reconstituted in 0.5 mL of cholorform and agitated 
with a Vortex mixer. Then, the extract was diluted with 0.5 mL of hexane and applied 
with a micropipette onto the wet column. The vial, containing the extract, was washed 
with 0.1 mL of a chloroform-hexane (1:1) solution and this wash was also applied onto 
the column. The column was first washed with 5.0 mL of hexane and finally with 5.0 
mL of fresh ethyl ether. Aflatoxins were eluted with 3.0 mL of chloroform-ethanol (95:5 
v/v) solution into clean scintillation vials. The eluted extract was evaporated to dryness in 
a warm (35-40°C) water bath under a nitrogen stream.
Aflatoxin Detemination
Aflatoxin standards and samples were derivatized according to the AOAC 
Official Method 990.33 H-I (Park et al., 1990). Briefly, the dry extracts were 
reconstituted in 200 pL of hexane and 100 pL of TFA (trifluoroacetic acid) were added. 
Using a Vortex mixer, this mixture was shaken for exactly 30 sec and let stand for 5 min. 
This solution was diluted with 4.0 mL of distilled water-acetonitrile (9:1 v/v) and shaken 
for 30 sec. The aflatoxin quantification was carried out using a Beckman modular High 
Performance Liquid Chromatograph with a Microsorb-mv C-18 reverse phase column 
using water-acetonitrile-methanol (70:17:17 v/v) as a mobile phase at a flow rate of 1.25 
mL/min and a Varian fluorichrom fluorescence detector, wave length set at 365 nm. 
Chromatograms were obtained from a Varian 4270 integrator.
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6.- Ethanol Determination
The ethanol present in the supernatant after fermentation of com was determined 
according to the AO AC 984.14 A-E (AO AC, 1990) method; isopropanol was used as an 
internal standard. Briefly, the 4.0 mL samples o f the supernatant were let thaw at room 
temperature and 100 pL of this sample were combined with 100 pL of a 5% (w/v) 
isopropanol solution. The sample-isopropanol mixture was injected into a Varian model 
3700 gas chromatograph. The gas chromatograph was equipped with a 5 mm x 6 m glass 
column which was packed with 0.2% Carbowax on GP 60/80 Carbopack C/O. The 
temperature o f the column was 100°C. The chromatographs were obtained from a Varian 
4270 integrator.
7.- Statistical Analysis
Scheffe’s test was used to determine differences among means o f aflatoxin levels 
after fermentation in the presence of ammonia and after fermentation using peroxides 
and ammonia. The same test was used to determine differences among means of ethanol 
levels after the same treatments. One-way analysis of variance (SAS, 1988) was used to 
differences between controls and treatments after being grouped according to the 
peroxide used. An alpha value o f 0.05 was used for all analyses.
IV.- Results and Discussion
1.- Detoxification with Ammonium Persulfate
Aflatoxin-contaminated com was exposed to ammonium persulfate in order to 
observe the effect o f this chemical on the AFB, levels remaining in com after 
fermentation. Contaminated com was exposed to 0.0, 0.25, 0.50, 0.75, 1.0, 1.5, and
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2.0% (w/w) ammonium persulfate during the fermentation process. Aflatoxin levels were 
determined in the distillers’ dried solid grains (DDSG) remaining after fermentation for 
each level o f ammoniation, as well as in the original com. The fermentation process, by 
itself, reduced aflatoxin levels by 50% in the com. This represents over 50% of APB, 
reduction in the com after fermentation. After AFB,-contaminated com was fermented in 
the presence o f ammonium persulfate, AFB, analysis showed that all levels of 
ammoniation (except 0.75%) significantly (P < 0.05) reduced the level of AFB,in the 
remaining DDSG, compared to the original com (Table 3.1). The greatest AFB,reduction 
(>85%) was achieved when 2.0% (w/w) ammonium persulfate was incorporated into the 
process. This results are consisting with previous reports (Samarajeewa et al., 1990; 
Phillips et al., 1994). This results indicate that the addition of 2.0% of ammonium 
persulfate can successfully reduce aflatoxin levels in affected com. However, it was also 
important to know the effect of ammonium persulfate the ethanol production.
2.- Effect of Ammonium Persulfate on Ethanol Production
After 72 hours o f fermentation, samples from the supernatant were taken and 
analyzed for their ethanol content. In Table 3.2, the addition of ammonium 
persulfate did not significantly (P < 0.05) affect ethanol production. These results are 
consistent with previous studies where fermentation procedures were carried out 
using ammonia treated com (Lillehoj and Lagoda, 1979; Nofsinger and Bothast, 
1981; Bothast et al., 1982; VanCauwenberge et al., 1982).
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Table 3.1.- Effect of ammonium persulfate on the aflatoxin B, content of contaminated 
com after fermentation
NH4S20 8 added AFB, in DDSG ’ (ng/g) Decontamination level
(% w/w) (% )
Original com 178b ± 15 -
0.00 79bc ± 10 55.62
0.25 831* ± 35 52.98
0.50 46bc ± 6 71.92
0.75 135^ ± 1 23.65
1.00 43bc + 7 75.87
1.50 32bc ± 4 81.52
2.00 23bc ± 1 86.95
“Distiller’s dried solid grains. 
b Values are means of three replicates ± standard error.. 
“Significantly different from original com (P < 0.05).
In all these studies, the treatment of com with ammonia previous to 
fermentation, caused an increase in the treatment o f com with ammonia previous to 
fermentation, caused an increase in ethanol yields.
Table 3.2.- Effect of ammonium persulfate on the ethanol production during 
fermentation of aflatoxin-contaminated com.
NH4S20 8 added (% w/w) Ethanol content" (%)
0.00 8.0 ± 0.4b
0.25 8.1 ± 0.2b
0.50 8.3 ± 0.3b
0.75 8.1 ± 0.6b
1.00 7.9 ± 0.2b
1.50 7.3 ± 0.2b
2.00 7.8 + 0.1b
“Values are means of three replicates ± standard error. 
bNot significantly different (P < 0.05).
In the present study; however, the ethanol yields did not increase compared to the 
control, the ethanol production was not affected.
56
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3.- Effect of Peroxides and Ammonium Persulfate on the Ethanol Production
To increase the ethanol production during fermentation, the effect o f some 
chemicals on ethanol production, has been studied (VanCauwenberge et al., 1982). In the 
present study, the effect of azodicarbonamide, benzoyl peroxide, and hydrogen peroxide 
on the ethanol production was investigated. The peroxides were incorporated into the 
fermentation process at two different concentrations (0.5 and 1.0%) and during three 
different stages, liquefaction, saccharification, and fermentation. Results of this study are 
shown in Figure 3.3.
As can be observed in Figure 3.3, the incorporation of 2.0% (w/w) of ammonium 
persulfate into the fermentation process did not affect the ethanol production compared to 
the control (no ammonia added). This is consistent with previous experiments in the 
present study (Lillehoj and Lagoda, 1979; Nofsinger and Bothast, 1981; Bothast et al., 
1982; VanCauwenberge et al., 1982). When comparing the addition of each chemical, 
regardless o f the concentration, either to the control (no NH4) or to the fermentation 
control (NH4 added), neither azodicarbonamide nor hydrogen peroxide had a significant 
effect on ethanol production. However, the addition of benzoyl peroxide showed a 
significant negative effect on ethanol production.
The effect o f the concentration o f peroxides in the fermentation process on the 
ethanol yields was also analyzed. Even though, there were no statistical difference 
between processes using 0.5 and 1.0% of either azodicarbonamide, or hydrogen 
peroxide, a trend was observed. The use of 0.5% appeared to cause increased ethanol 
production, while the addition of 1.0% seemed to cause the opposite.
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Figure 3.3.- Ethanol production from com treated with 2% ammonium persulfate with and without addition of 0.5% and 1.0% 
peroxides during liquefaction (L), saccharification (S), and fermentation (F). C-NH4 = 2.0% ammonium persulfate without 
addition of peroxides, Control = No chemicals added. Values are means of three replicates. AZ = azodicarbonamide; BP = 
benzoylperoxide.
In the case of benzoyl peroxide, the incorporation of 1.0% of this chemical to the
fermentation process significantly decreased the ethanol yields when it was added during
saccharification and fermentation. When 1.0% of this peroxide was added during
liquefaction, there was no significant effect on the ethanol yields. Interestingly, 0.5%
benzoyl peroxide did not have a statistically significant effect on the ethanol production;
the incorporation of this chemical at this concentration, achieved the highest ethanol
concentrations for the fermentation process. This was observed when 0.5% benzoyl
peroxide was added during liquefaction and saccharification stages.
4.- Effect o f Peroxides and Ammonium Persulfate on the Aflatoxin B, Content in 
Fermented Corn
After evaluating the effect of ammonium persulfate in combination with either, 
azodicarbonamide, benzoyl peroxide or hydrogen peroxide on ethanol production, the 
effect of these chemical combinations on the aflatoxin content in DDSG was also 
investigated. These results are shown in Figure 3.4. As observed previously (Table 3.1), 
the fermentation process significantly reduced the levels of AFB, in the DDSG; similar 
results were obtained in this experiment. In this experiment, a significant reduction in the 
toxin levels were also observed when com was fermented in the presence of 2.0% 
ammonium persulfate. This, confirms that 2.0% ammonium persulfate is effective in 
reducing AFB, levels in com during the fermentation process. After the addition of 
chemical to the fermentation process (regardless o f chemical concentration, and point of 
addition) o f AFB,-contaminated com in the presence of ammonium persulfate, a 
significant change in the AFB, content o f DDSG was observed.
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Control AZ (1% ) BP(1% ) H 2 0 2 (l% )
A Z  (0.5% ) BP(0.5% ) H2O2(0.5% )
Treatment
Figure 3 .4 .-  A fla tox in  B , (A F B 1 ) lev e ls  in naturally-contam inated corn ferm ented w ith  2.0%  am m onium  persulfate w ith  and 
without addition of selected peroxides. AZ = azodicarbonamide, BP = benzoyl peroxide; OC = Original com; FC = 
Fermented com; FCA = Fermented com + 2.0% ammonium persulfate; L = Liquefaction; S = Saccharification; F = 
Fermentation. Values are means of three replicates.
This change was statistically evaluated by comparing the toxin levels found in the 
DDSG after fermentation with peroxides to those in the original com, fermented com, 
and fermented com with ammonium persulfate. In order to evaluate the effect of 
peroxides on the AFB, reduction by ammonium persulfate, levels of AFB, in com 
fermented with peroxide addition were compared to the AFB, levels in the com 
fermented in the presence of just ammonium persulfate.
The addition of 0.5%azodicarbonamide, for each fermentation stage, did not 
have a significant effect on the AFB, reduction; however, when the concentration o f this 
chemical was increased to 1.0% the efficacy of ammonium persulfate to lower AFB, 
levels was compromised. The reduction of AFB, levels by 87% achieved in the control 
decreased approximately 73% when the chemical was added during liquefaction and 
saccharification, and by 50%, when addition was during fermentation. For benzoyl 
peroxide and H20 2, a similar pattern was observed. Similar lowering in the AFB, 
concentration was observed when 1.0% of either peroxide was added during liquefaction 
and saccharification and it was emphasized when the addition was done during 
fermentation. However, when 0.5% of these chemicals was used, a slight difference in 
the outcomes were observed.
Even though, the addition o f 0.5% of benzoyl or hydrogen peroxide did not 
significantly change the percentage of AFB, reduction achieved by 2.0% ammonium 
persulfate, addition of 0.5% benzoyl peroxide during fermentation, and addition of 0.5% 
hydrogen peroxide during saccharification, increased by 10% the AFB, reduction 
obtained by the control.
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5.- Mutagenic Potential Distillers’ Dried Solid Grains (DDSG)
In order to evaluate the potential risk that these processes may have on the final 
product, the mutagenic potential of the DDSG was determined. The Salmonella / 
microsomal mutagenicity test, (Ames test) (Maron and Ames, 1983), was carried out 
using Salmonella tester strain TA100 with and without metabolic activation (S9). 
Aflatoxin B, is known to require bioactivation by S9; however, the possibility o f the 
formation of aflatoxin-ammonia-, aflatoxin-peroxides-, ammonia -peroxides-, or 
aflatoxin-ammonia-peroxides-reaction products that may not require metabolic 
activation, required the test performance without S9. Pure AFB, was used as positive 
control and its response to this test with and without S9 is shown in Figure 3.5.
To test the different fermentation processes for their mutagenic potential, 5 gm of 
each DDSG sample was extracted with acetone, evaporated to dryness and reconstituted 
in 1 mL DMSO. Results of the mutagenicity test are shown in Figure 3.6. A response is 
considered mutagenic when the number o f revertants/plate caused by an agent or sample 
double the number of spontaneous or natural revertants/plate. In this case, the number of 
natural revertants/plate were 147+ 13. All the procedures or controls failed to produce a 
mutagenic response. However, opposite to what was expected, the original com did not 
show signs of mutagenicity, even though, the AFB, content was 144 ng/g. Even more 
surprising, com spiked with enough pure AFB, to induce mutagenicity in Salmonella 
TA100, also failed to yield the expected mutagenic response (Figure 3.5).
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Figure 3.5.- Mutagenic potential of pure AFBj and AFBi-spiked original com (CO) in the Salmonella / microsomal 
mutagenicity assay, using tester strain TA100 with and without metabolic activation (S9). The values for natural revertants 
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Figure 3.6.- Comparative antimutagenic potentials o f naturally AFBi-contaminated com treated with 2.0% ammonium 
persulfate and with and without peroxides, as determined by the Salmonella/microsomal mutagenicity assay using tester strain 
TA100 with S9. AZ = azodicarbonamide, BP = benzoyl peroxide, OC = Original Com, FC = Fermented com, FCA = 
Fermented com + 2.0% ammonium persulfate, L = Liquefaction, S = Saccharification, F = Fermentation, NR = Natural 
revertants. Values are means of three replicates.
These results were consistent with the results obtained by Weng et al. (1997) 
while studying the mutagenic potential o f ammonia/aflatoxin reaction products. They 
found that highly (7500 ng/g) AFB,-contamianted com failed to show mutagenicity in 
the Ames test using Salmonella tester strain TA100.
In summary, the study focused in the effect o f  ammonium persulfate on the final 
AFB, concentration in the DDSG, indicated that the more ammonium pesulfate is added, 
the more detoxification is achieved. The ammonium persulfate levels used (0.5-2.0%) 
are those commonly used in high-temperature/high pressure decontamination procedures 
were ammonia is used (Phillips et al., 1994). The liquefaction step, during the 
fermentation process, involves temperatures above 100°C and pressure superior to 1 atm. 
(autoclaving conditions). The incorporation of 2.0% ammonium persulfate was 
demonstrated to be the fermentation procedure that destroy more AFB,, among those 
including only addition of ammonium persulfate. In addition, the incorporation of 
ammonium persulfate in the fermentation o f com, did not affect the production of 
ethanol, which is the most important product in alcoholic fermentation. Even though 
previous studies (Lillehoj and Lagoda, 1979; Nofsingerand Bothast, 1981; Bothast etal., 
1982; VanCauwenberge et al., 1982) demonstrated that the incorporation of ammonia in 
the fermentation o f com increased the ethanol yield, the results of this study were 
inconsistent with these investigations, by demostrating that ammonia (in the form of 
ammonium persulfate), did not affect he ethanol yield. Therefore, the use of 2.0% 
ammonium persulfate was found suitable to decontaminate AFB,-contaminated com 
during fermentation. While evaluating the effect of different concentrations of peroxides
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on both, the ethanol production and the degree of AFB, decontamination in the DDSG, it 
was found that only benzoyl peroxide (regardless of concentration) had a significant 
effect on both parameters. As it can be observed in Figures 3.3 and 3.4, the addition of
0.5% benzoyl peroxide during liquefaction and saccharification raised the ethanol yields 
from ca. 8.0% (controls) to almost 10.0%; however, this was not statistically significant. 
Interestingly, the addition o f benzoyl peroxide, at the same concentration but during 
fermentation, increased the level of decontamination from 87% (control ) to 97%. This 
was also not statistically significant. However, this results showed that the best 
fermentation procedure tested for the decontamination of AFB,-contaminated com, was 
that protocol that included the addition of 2.0% amonium persulfate + addition of 0.5% 
benzoyl peroxide during the fermentation step. For ethanol production, the same 
parameters gave the best results, but the addition of the peroxide should be done in either 
the liquefaction or saccharification step.
Finally, all these fermentation procedures showed no mutagenic response in the 
mutagenicity assay. However, fermentation control, as well as original com surprisingly 
failed to show the mutagenic response expected from the AFB, levels present in these 
samples; this phenomenon has been previously observed. Weng et al. (1997), while 
studying the mutagenic potential of ammonia/aflatoxin reaction products in com, 
observed that AFB,-contaminated com did not show the expected mutagenic response in 
the Ames test using Salmonella tester strain TA100. Based on that observation and other 
studies (Lee et al., 1984; Lawlor et al., 1985; Haworth et al., 1989). The authors 
suggested the presence of what they called “ unknown interfering materials” in the com
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that, in some way, decreases or inhibits the mutagenic potential of AFB,. The present 
study yielded results that were consistent with these findings and produced a starting 
point for the next phase of this project.
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CHAPTER 4. ISOLATION OF ANTI-MUTAGENIC COMPOUNDS FROM
CORN
I.- Rationale
In the previous study (CHAPTER 3) AFBi-contaminated com failed to produce 
a mutagenic response in the Ames test and the presence o f anti-aflatoxin factors in the 
com was suggested. In this study, com was extracted and fractionated with a thin layer 
chromatography (TLC) technique using different developing solvent systems. The 
Salmonella/mammalian microsomal mutagenicity assay (Ames test) was used as a 
monitoring test for anti-mutagenic activity in the com fraction. Both, Salmonella tester 
strains TA98 and TA100 with metabolic activation (S9) were used. Several com 
fractions, at different stages in the isolation process, showed anti-mutagenic dose- 
response when exposed to pure AFBi. Com extracts were not toxic to none of two 
tester strains. After four consecutive TLC fractionation steps, the bands that showed the 
best anti-mutagenic dose-responses were selected for further partial characterization 
analyses.
II.- Introduction
While studying the mutagenic potential of aflatoxin/ammonia reaction products, 
Weng et al. (1997) observed that com containing extremely high (7500 ppb) 
concentrations o f AFBi was not mutagenic in the Ames test, using Salmonella tester 
strain TA100 with metabolic activation. They suggested the presence of what they 
named “unknown interfering materials” that have the property of inhibit the mutagenic 
potential of AFBi in the Ames test. These findings were consistent with previous
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studies (Lee et al., 1984; Lawlor et al., 1985; Haworth et al., 1989) where the com 
matrix was suspected of interfering with AFBi mutagenic activity.
Many phytochemicals in vegetables and fruits have been isolated and 
identified as agents that can block different stages in the carcinogenesis process in 
several animal models (Huang et al., 1994). Compounds such as isothiocyanates, 
indoles, monoterpenes, vitamins, carotenoids, flavonoids, etc., have been found to 
have anti-mutagenic and anti-carcinogenic activities with different mechanisms of 
action (Huang et al., 1994; Namiki, 1994).
Weng et al. (1997) found that these interfering materials can be extracted 
together with AFBi using dimethyl chloride (CH2 CI2). They also suggested that 
further studies are required using a sequential fractionation of the com extracts in 
order to isolate the active compounds.
This study, which is the second part o f this project, addressed an extraction 
and isolation procedure of the active materials from com. The objective of this study 
was to isolate the compounds responsible for the anit-mutagenic character o f the 
com extracts previously studied by Weng et al. (1997).
ID.- Materials and Methods
1.- Chemicals
Magnesium sulfate, sodium ammonium phosphate, D-biotin, L-histidine, 
ampicillin, tetracycline, sodium dihydrogen phosphate, beta-nicotinamide adenine 
dinucleotide phosphate (NADP, sodium salt), silica gel, calcium sulfate, and glucose-6- 
phosphate (Sigma-Aldrich, St. Louis, MO), citric acid monohydrate, potassium
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phosphate, dibasic, anhydrous, potassium chloride, chloroform, methylene chloride, 
methanol, dimethyl sulfoxide, hexane, ethyl ether anhydrous, and water (HPLC grade) 
(Mallinckrodt Baker, Inc., Paris, Kentucky), magnesium chloride (Baker Inc., 
Phillipsburg, NJ), disodium hydrogen phosphate, sodium chloride (EM Science, Cherry 
Hill, NJ) bacto agar and crystal violet (Difco-Laboratories, Detroit Michigan), glucose 
(Fisher Scientific, Fair Lawn, NJ), acetonitrile (Baxter, Muskegon, MI), acetone 
(Chempure, Houston, TX), ethanol (Aaper Alcohol and Chemical Co., Shelbyville, 
Kentucky), Oxoid nutrient broth No.2 (Unipath LTD., Basingstoke, Hampshire, 
England), post-mitocondrial supernatant (S9 mix) (Molecular Toxicology, Inc., Boone, 
NC). Aflatoxin Bi standard was kindly provide by Dr. Mary W. Trucksess, Food and 
Drug Administration, Washington, D. C.
2.- Corn Samples
Clean and naturally aflatoxin-contaminated com was obtained from Texas, 
kindly provided by Dr. Jeff Ellis, Texas Office of the State Chemist. The samples were 
labeled and stored in plastic bags at 4°C. Several samples of different varieties of clean 
com were kindly provided by Dr. Manjit S. Kang, Department of Agronomy, Louisiana 
State University Agricultural Center. These samples were immediately ground and 
extracted for further analysis.
3.-Aflatoxin Determination
The extraction of aflatoxin from the com samples was carried out according to 
the method described by Thean et al., (1980) which has been described in detail in 
CHAPTER 3.
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The derivatization procedure was carried out by dissolving the dry extracts in
3.0 mL of acetonitrile-water (9:1); then, 200 pL of this solution was combined with 700 
pL of a mixture o f trifluoroacetic acid + acetic acid. This final solution was incubated at 
65°C for 8.5 min in a water bath.
The derivatized samples were injected into a Waters 600 Controller HPLC, 
using a Waters 717 plus Autosampler. Acetonitrile-water (20:80) was used as the 
mobile phase, at a flow rate 2 mL/min and 2700 psi pressure. The chromatograms were 
obtained from a Waters 486 Tunable Absorbance Detector. All the aflatoxin analyses 
were conducted in the Microbiology and Mycotoxins Laboratory, Department of 
Agricultural Chemistry, Louisiana State University Agricultural Center.
4.-Preparation of Corn Extracts
All com samples were ground in a Brinkman Retsch mill, type ZM 1, model 
65297, using a No. 1.0 Brinkman Retsch mill screen. In order to prepare the com 
extracts (Figure 4.1), four portions o f 100 grams each of ground com were placed 
inside 1000 mL Erlenmeyer flasks and 500 mL methylene chloride were added to each 
flask. All flasks were shaken for 30 min using a wrist action shaker (Burrell Wrist 
Action Shaker, model 75, Pittsburg, PA), at speed grade 2. The mixture from each flask 
was filtered through a Whatman No. 4 filter paper under vacuum. All filtrates 
(approximately 450 mL each) were combined with the others and concentrated to 
approximately 20 mL using a rotoevaporator (Brinkman Buchi rotaevaporator, model 
RE121, Switzerland) at 37°C and rotated at 60 rpm. The com extract was finally 
adjusted to 25 mL with methylene chloride and stored at 4°C until further use.
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Ground corn (400 gm )
Filtrate w/Whatman N o . 4 
under vaccum
Adjust to 25 mL W/CH2 CI2 , 
store at 4°C.
Extract W/CH2 CI2 (1:5 w /v)  
during 30 min /  agitation
Anti-m utagenesis testing or 
Thin Layer Chromatography
Concentrate the filtrate to 
ca. 20-25 mL w/rotavapor  
at 37°C, 60 rpm
Figure 4.1.- Procedure for the preparation o f com extracts for anti-mutagenesis 
testing and thin layer chromatography
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5.- Corn Extracts Fractionation (Thin Layer Chromatography)
Com extracts were fractionated using preparative thin layer chromatography 
(TLC) (Figure 4.2). All the preparative TLC plates were prepared by coating 20 cm x 
20 cm glass plates with a 1.0 mm thick layer of a slurry of silica gel H (10-40 pm) in 
distilled water (1:2 w/v). Calcium sulfate (5.0 % w/w) was added as a binder. Coated 
preparative-TLC plates were dried at 60 C for 1 h and allowed to activate for another 2 
h at the same temperature.
In order to start the fractionation of the com extracts, 6.25 mL of concentrated 
com extracts were carefully applied as a streak with a 100 pL micropipette onto 
preparative-TLC plates at 3.0 cm from the lower edge of the plate. The plate was then 
placed inside o f a TLC chamber previously equilibrated with approximately 150 mL of 
mobile phase. The chromatogram was developed until the solvent front reached 0.5 -
1.0 cm from the top edge of the TLC plate. The solvent front was marked and the plate 
removed out o f the chamber and dried under a hood. The dried plate was observed 
under long wavelength UV light (260nm). With the aid of UV light, different 
fluorescent regions apparent on the plate were marked and the Rf measured. Silica from 
these regions was scraped off the plate and extracted with 2 x 25 mL of chloroform- 
methanol-acetone (8:1:1) and filtered through a Whatman No.4 filter paper. These 
fractionated extracts were dried under a nitrogen stream and analyzed for anti­
mutagenicity activity. The fractionated extracts that yielded a positive anti-mutagenic 
response in the Ames test were refractionated following the same procedure described 
above but using a different solvent system as a mobile phases.
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Figure 4.2.- Thin layer chromatography (TLC) procedure for the fractionation of 
com extracts and anti-mutagenically active com fractions.
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6.- Growth Inhibition Area Test (rfa mutation test)
This test was used to observe the effect of a fraction of the TLC fractionated 
com extract on the permeability of the Salmonella cell membrane to a crystal violet 
solution. The extract was reconstituted and serially diluted in DMSO. One-hundred 
microliters o f sample were combined with 100 pL (106- 10s CFU/mL) o f Salmonella 
tester strain TA98 culture in a test tube containing 2.0 mL of top agar and poured onto a 
master plate. Master plates contained L-histidine, D-biotin and ampicillin. After the top 
agar hardened, a filter paper disc, containing 3 pL of crystal violet solution, was
o
aseptically placed in the center of the plate. Plates were incubated at 37 C for 48 h and 
the diameter of the growth inhibition area around the filter paper disc was measured. 
This test was carried out in duplicate.
7.- Anti-mutagenicity Determination
The determination o f anti-mutagenicity activity towards AFBi in the com 
extracts was carried out using the Salmonella /microsomal mutagenicity assay (Ames 
test) described by Maron and Ames (1983). The dry extracts, obtained either directly 
from com or from preparative-TLC fractionation of com extracts, were reconstituted 
and diluted (0, 5, 25, 125 and 625 times) with DMSO. At the same time, each dilution 
was spiked with pure AFBi to a final concentration of 500 ng of AFBi/100 pL of 
diluted extract. These solutions were then assayed using the plate incorporation 
procedure of the Ames test. Briefly, 100 pL of sample were combined with 100 pL of 
each tester strain bacterial culture (Salmonella tester strains TA98 and TA100) and 500 
pL of S9 mix in a test tube containing 2.0 mL of top agar. This mixture was poured
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onto minimal glucose agar plates and incubated at 37 C for 48 h. The numbers of 
revertants were manually obtained using a Bactrovic colony counter (model C-110, 
New Brunswick Scientific Co., New Brunswick, N.J.) and compared against a standard 
curve. The standard curve was obtained for both tester strains using different AFBi 
concentrations. Biochemical tests on the histidine requirement, rfa mutation, and R- 
factor were conducted each time the mutagenicity assay was performed. All the assays 
were carried out in triplicate.
IV.-ResuIts and Discussion
This phase o f the current research focused on the isolation o f compound(s) 
present in com that cause a decrease or inhibition of the mutagenic potential of 
AFBi. Previous studies (Lee et al., 1984; Lawlor et al., 1985; Haworth et al., 1989) 
have shown that the mutagenic potential of AFBi varies depending on whether the 
toxin is in a pure form or contaminating a commodity. More recently, Weng et 
a/.(1997) observed that com containing high (7500 ppb) amounts o f AFBi, failed to 
showed mutagenicity in the Ames test, using Salmonella tester strain TA100 with 
metabolic activation. This phenomenon, which was also observed in the current 
project (CHAPTER 3), is the focus of this part o f the present research.
l.-M utagenic Potential of Unfractionated Corn Extracts
AFBi-contaminated and AFBi-free com (clean com) were analyzed for their 
concentration of AFBi; results of the analysis showed that contaminated com 
contained 453 ppb AFBi, while no AFBi was detected in the clean com sample. 
These com samples were extracted with CH2CI2 as previously described.
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Clean and contaminated com extracts were re-dissolved and diluted in 
DMSO for the mutagenicity test. A third sample was obtained by spiking clean com 
extract with AFBi to provide approximately 222 ng AFBi per plate in the 
mutagenicity test. These samples were finally tested for mutagenicity using 
Salmonella tester strains TA98 and TA100, with and without metabolic activation, in 
the Ames test. Results are shown in Figures 4.3 - 4.9. Values are shown in Appendix 
A.
The mutagenic response o f pure AFBi was tested with both tester strains, 
with and without metabolic activation. As can be observed in Figure 4.3, AFBi 
required to be bioactivated by S9 to the reactive metabolite in order to cause 
mutagenicity in both tester strains. The absence o f S9 caused the number of 
revertants per plate in both tester strains to remain within the spontaneous reversion 
normal range. When clean com extracts were tested, the expected lack o f mutagenic 
response was observed for both tester strains, TA98 (Figure 4.4) and TA100 (Figure 
4.5) with or without S9. These results indicated the absence of either direct or 
indirect potentially mutagenic material in the com.
When AFBi-contaminated com extracts were tested, mutagenic response was 
again not observed. Contaminated com extracts provided approximately 67.5 ng 
AFBi per plate. This amount of AFB] was highly mutagenic in both tester strains 
with metabolic activation.However, this same amount o f AFBi present the com 
failed to show the corresponding mutagenicity in both, TA98 (Figure 4.6) and 
TA100 (Figure 4.7) in the presence of S9.
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Figure 4.3.- Standard curves for pure AFB, using Salmonella tester strains TA98 and TA100 with metabolic activation.
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Figure 4.4.- Mutagenic potential of AFB,-free com (AFB1-FC) using Salmonella tester strain TA98 with and without
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Figure 4.5.- Mutagenic potential of AFB,-ffee corn (AFBl-FC)using Salmonella tester strain TA100 with and without S9.
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Figure 4.6.- Mutagenic potential of aflatoxin B,-contaminated com (AFB1-CC) using Salmonella tester strain TA98 with and
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Figure 4.7.- Mutagenic potential of aflatoxin B,-contaminated com (AFB1-CC) using Salmonella tester strain TA100 with
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Figure 4.8.- Mutagenic potential o f AFBr spiked‘ com (AFBl-SC) using Salmonella tester strain TA98 with and without 
metabolic activation. Values are means o f three replicates.
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Figure 4.9.- Mutagenic potential of AFB, spiked1 com (AFBl-SC) using Salmonella tester strain TA100 with and without
metabolic activation. Values are means of three replicates.
1 Com extracts were spiked with AFB, to provide 222 ng AFB,/plate.
In order to confirm the existence o f material that interferes with the 
mutagenic potential o f AFBi in the Ames test, clean com extract was spiked with 
enough AFBi to provide 222 ng of toxin per plate. Again, these AFBi spiked extracts 
failed to show mutagenic potentials, even at the lowest dilution, for both tester 
strains (Figures 4.8 - 4.9). Even though inhibition of AFBi mutagenicity was 
observed, a dose-response relationship between com extract concentration and AFBi 
mutagenicity was not obtained. During these assays, the ratio between com extract 
and AFBi never varied, since the dilution o f extracts was done after spiking. It was 
necessary; however, to demonstrate that the mutagenicity of AFBi could have be 
restored as the com extract concentration (relative to AFBi concentration) decreases. 
Consequently, an anti-mutagenesis assay was performed. For this purpose, clean and 
AFBi-contaminated com extracts were concentrated and diluted, and each one o f the 
dilutions was spiked with enough AFBi to provide 500 ng of toxin per plate. It is 
important to mentioned this, since data from the previous experiment and literature 
demonstrated that AFBi did not show mutagenic activity in the absence o f S9, the 
rest of the mutagenic assays were performed only with metabolic activation. Results 
from this assay showed that, as the concentration of either clean or AFBj- 
contaminated com extract decreased, the mutagenicity o f a constant amount (500 ng) 
o f AFBi was restored. These results were similar using both Salmonella tester strain 
TA98 (Figure 4.10) and TA100 (Figure 4.11). This dose-response type relationship 
suggests that one or more o f the com constituents has an inhibitory effect against 
AFBi; limited by concentration. Individual results are presented in Appendix A.
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Figure 4.10.- Anti-mutagenic potential of AFB,-contaminated com'(AFC-CC) and AFB,-free com'(AFBl-FC) using 
Salmonella tester strain TA98 with metabolic activation. Original extract (0) was concentrated (5 and 25 times) and diluted 
(5, 25, 125, and 625 times), respectively. Pure AFB, control (500 ng/plate) caused 115 revertants/plate. Values are means of 
three replicates.
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Figure 4.11.- Anti-mutagenic potential of AFB,-contaminated com'(AFBl-CC) and AFB,-free com'(AFBl-FC) using 
Salmonella tester strain TA100 with metabolic activation. Original extract (0) was concentrated (5 and 25 times) and diluted 
(5, 25,125, and 625 times), respectively). Pure AFB, control (500 ng/plate) caused 610 revertants/plate. Values are means of 
three replicates.
1 Spiked with 500 ng pure AFB,/100pL
These results were consistent with Weng et al (1997) in showing that AFBi 
mutagenicity was decreased or inhibited when in contaminated com. Pure AFBi was 
shown to be highly mutagenic in the pure form; however, when pure AFBi was 
combined with com extract, the usual mutagenic response was absent. Therefore, the 
anti-mutagenesis assay was carried out. The anti-mutagenesis assay consisted of 
exposing a constant concentration of AFBi to different concentrations o f the 
suspected inhibitor (com extract) and tested the mutagenicity o f AFBi in the Ames 
test. The results showed a dose-response type of relationship when the ratio com 
extract:AFBi concentration varied. These results are in agreement with Weng et al. 
(1997) where the presence o f an unidentified material(s) in com capable of reducing 
or inhibiting the mutagenicity o f AFBi was observed. In order to investigate the 
presence of these interfering materials or anti-aflatoxin compounds in com, extracts 
obtained form clean and AFB i-contaminated com were fractionated using thin layer 
chromatography (TLC) procedures and the Ames test was used as a monitoring tool.
2.- Fractionation o f corn extracts (TLC 1)
In order to initiate the isolation of the anti-aflatoxin factor(s) from the CH2CI2 
extracts, thin layer chromatography (TLC) was performed to fractionate these 
extracts. Briefly, a volume of extract (equivalent to 20 gm of com) from both clean 
and AFBi-contaminated com, was fractionated on a 1 mm preparative silica gel TLC 
plate and developed with chloroform-acetone (15:1). After the preparative TLC 
plates were spotted, developed, dried, and observed under UV light, three regions 
were identified between the origin and the solvent front.
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The first region included the material that migrated from Rf = 0.0 (origin) to 
Rf = 0.1 and was designated B l. In this region, very light colored, undefined bands 
were observed, apparently overlapping with a poorly defined material that reached 
the top o f this region.
The second region, designated B2, contained the characteristic blue AFBi 
band and some poorly defined very light blue colored material. This region ranged 
from Rf = 0.1 to Rf = 0.3. The third region (B3) ranged from R f = 0.3 to Rf = 1.0 
(solvent front). This last region contained a very defined bright green band, at Rf 
approximately 0.3 -  0.5, followed by a combination of bright yellow, very bright 
blue, and light blue colored material that were not defined in a band form.
These three regions were scraped off the plate and the materials contained in 
the silica were extracted with 2 x 20 mL chloroform-acetone-methanol (8:1:1) and 
evaporated to dryness under N2 . In addition, a control portion (ca 3.0 gm) of the 
silica gel was also scraped off a region of the plate were no test material was applied. 
The silica gel was subjected to the same extraction procedure (mentioned above) and 
the resultant extract was tested for its effect on the mutagenic potential of AFBi with 
the purpose of having a control over the chromatographic procedure.
All extracts were diluted and every dilution spiked with pure AFBi to provide 
500 ng o f toxin per plate. From this point, the anti-mutagenic activity of all extracts 
was monitored for a dose-response type o f relationship where the level o f aflatoxin 
present in the extracts dilution was constant. The anti-mutagenic assay performed on 
these com fractions showed that all (either from clean or contaminated com)
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decreased to some extent, the mutagenicity o f 500 ng AFBi (Figures 4.12 - 4.13). 
However, not all follow the same pattern. Fraction B l, from both com extracts, 
decreased the mutagenicity o f AFBi at the highest concentration; however, after the 
first dilution this was back to normal. Fraction B3 behaved in a similar manner to Bl 
when obtained from clean com and tested on both Salmonella strains; however, 
when this fraction was obtained from aflatoxin-contaminated com, it showed a 
different dose-anti-mutagenic response type o f relationship with AFBi mutagenicity 
(Figures 4.14 - 4.15). In the case o f the B2 fraction, a standard dose-response type 
behavior was observed for both kinds o f com and on both tester strains (Figures 
4.12 - 4.15). Another important feature o f fraction B2 anti-mutagenic activity was 
the fact that at the highest B2 fraction concentration, the number o f revertants per 
plate was lowered to the number of spontaneous revertants. This event was observed 
consistently throughout the study. The extract obtained from silica gel did not have 
an effect on the mutagenicity o f AFBi (Figure 4.16). Individual results are presented 
in Appendix A. In order to select the chromatographic regions to be used for 
isolation o f the anti-aflatoxin factors), the slope and shape of the dose-response 
showed by each one o f the bands in the anti-mutagenesis assay were evaluated and 
compared. Fraction Bl consistently lost its potential anti-mutagenic activity after the 
first dilution and at the highest concentration was not capable of lowering the 
number o f revertants/plate to the number o f natural revertant values, as observed for 
fraction B2.
90





























Extract dilution (times diluted)
Bl
B3
— * r  -
Nat. Rev.
— o  -
Figure 4.12.- Anti-mutagenic potential of bands obtained from the TLC fractionation AFB,-ffee com extract, on Salmonella
tester strain TA98 with metabolic activation. Every dilution was spiked with AFB,to provide 500 ng AFB,/plate. Pure AFB,
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Figure 4.13.- Anti-mutagenic potential of bands obtained from the TLC fractionation of AFB,-free com extract, on
Salmonella tester strain TA100 with metabolic activation. Every dilution was spiked with AFB,to provide 500 ng AFB/plate.
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Figure 4.14.- Anti-mutagenic potential of bands obtained from the TLC fractionation AFB,-contaminated com extract, on
Salmonella tester strain TA98 with metabolic activation. Every dilution was spiked with AFB,to provide 500 ng AFB,/plate.




























Extract dilution (times diluted)
Nat. Rev.
Figure 4.15.- Anti-mutagenic potential of bands obtained from the TLC fractionation AFB,-contaminated com extract, on
Salmonella tester strain TA100 with metabolic activation. Every dilution was spiked with AFB,to provide 500 ng AFB,/plate.
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Figure 4.16.- Anti-mutagenic potential of silica gel, used on TLC plates, on Salmonella tester strains TA98 and TA100 with 
metabolic activation. Silica gel extract dilutions were spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB, control 
(500 ng/plate) caused 1318 and 3112 revertants/plate for TA98 and TA100, respectively. Values are means of three 
replicates.
For fraction B3, the other fraction that did not consistently lower the number 
of revertants to the spontaneous level, more information was required. These data 
suggests that fraction Bl possibly contained compounds with very low anti- 
mutagenic activity compared to fractions B2 and B3. Therefore, it was decided to 
study further the fractions which showed consistent and strong anti-mutagenic 
activity.
Growth Inhibition Area Test
During the TLC extraction and isolation procedure, it was observed that after 
evaporation fraction B3 showed an extremely oily appearance. This suggested that 
the potential lipid character of this fraction might have produced a physical 
interference between AFBi and the mutagenicity test microorganism. Mutagenicity 
studies performed on milk, obtained from lactating dairy cattle fed with ammoniated 
aflatoxin-contaminated whole cottonseed, were reported to be extremely variable due 
to fat interference (Ewaidah, 1984). In addition, fraction B3 obtained from clean com 
behaved very similar to fraction Bl (with both tester strains) and the extracts were 
more oily than those obtained from contaminated com. In order to test a possible 
physical interference from the fat material present in fraction B3, a biochemical test 
to confirm increased permeability on bacterial tester strains {i.e., exposure to crystal 
violet solution) was performed. Increased permeability o f  the cell membrane allows 
crystal violet to be more easily absorbed which would result in inhibition of bacterial 
growth, which is detected by the observing the growth inhibition area on the plate. 
The same dilutions o f fraction B3 used in the antimutagenesis assay were used in the
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growth inhibition test using Salmonella tester strain TA98. As was expected, as 
fraction B3 concentration decreased the growth inhibition area increased (Figure 
4.17). This suggested that the highly concentrated oily material in fraction B3 
interfered with the absorption of crystal violet by bacteria, either physically or 
chemically. However, the possible physical or chemical interference between 
bacteria and AFBi by fraction B3, can not be discarded as a possible anti-mutagenic 
mechanism o f one or more compounds present in this fraction. When compared to 
other fractions, band B2 showed the best and more uniform anti-mutagenic response; 
therefore, it was selected for further study on the isolation of possibly stronger anti- 
mutagenic factor(s).
3.- Fractionation of TLC Fraction B2 (TLC 2)
After fractionation o f non-contaminated and aflatoxin-contaminated com 
extracts, the anti-mutagenic activity of B2 was evaluated in both kinds of com 
samples. Data previously reported in this study supports the assumption that the anti- 
mutagenic factor(s) were intrinsic to the com and not to the fungi. Therefore, from 
this point, either clean or contaminated com was used for further fractionation of 
TLC fraction B2. The fraction B2 was obtained after 20 g of com were subjected to 
TLC 1, The extract form fraction B2 was applied onto a preparative silica gel TLC 
plate and developed with ethyl ether-methanol-water (95:4.5:0.5). After drying the 
TLC plate, five different regions were identified. The profile of this chromatographic 
separation is summarized in Table 4.1.
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Figure 4.17.- Effect of fraction B3 on the permeability of Salmonella tester strain TA98 cell membrane permeability to
crystal violet. AFB1-FC = AFB,-free com, AFB1-CC = AFB,-contaminated com. Values are means of two replicates.
5^99999998
Table 4.1.- Profile o f TLC 2 plate denoting fractionation o f the materials contained 
in region B2 separated after during TLC 1. _______
Region Bands contained (Rf) Description
Label Rf
B2A (0.0-0.022) Single band very light and bright 
blue color
B2B (0.022-0.1) Single band (0.07) faint blue
B2C (0.1-0.457) Single band (0.27) AFBi (blue)
















In the same way as it was done in TLC 1, the material from regions B2A,
B2B, B2C, B2D, and B2E were extracted, evaporated under N 2 , dissolved in DMSO, 
diluted, and spiked with 500 ng AFBi/100pL. These sample dilutions were then 
tested for anti-mutagenic activity using both Salmonella tester strains TA98 and 
TA100. Results o f  these assays are shown in Figures 4.18 and 4.19. individual results 
are presented in Appendix A.
Regions B2A, B2B, and B2C showed a consistent non anti-mutagenic 
response in both tester strains. Region B2A showed a loss o f anti-mutagenic activity 
in the highest concentration in relation to the second and third dilutions on tester 
strain TA98; however, this response was not evident after that. In tester strain 
TA100, region B2A showed no sign o f anti-mutagenic activity. Region B2B did not 
show anti-mutagenic activity in either tester strain. Even though region B2C lowered 
the number o f revertants closer to the number of spontaneous revertants than region
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Figure 4.18.- Anti-mutagenic potential o f bands obtained from the TLC fractionation of B2, using Salmonella tester strain
TA98 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB,
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Figure 4.19.- Anti-mutagenic potential of bands obtained from the TLC fractionation of B2, using Salmonella tester strain
TA100 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB,
control (500 ng/plate) caused 1800 revertants/plate. Values are means of three replicates.
B2A, it behaved similarly to region B2B, losing its little anti-mutagenic activity after 
the second dilution in both tester strain. Region B2D showed anti-mutagenic activity 
in both tester strains; however, for tester strain TA98 this response was not as 
intense. The anti-mutagenic response for region B2E, was the same for both tester 
strains. The highest anti-mutagenic responses were obtained from region B2D and 
B2E; however, the potent activity was with tester strain TA100. Based on these data, 
region B2E was selected for further studies in the isolation process o f  the anti- 
mutagenic factor(s).
4.- Toxicity of B2 and B2E
At this stage, it was important to test the toxicity o f the fractions that were 
producing anti-mutagenic responses. It had to be confirmed that the decrease in the 
number o f revertants/plate was due to the presence o f anti-mutagenic compounds in 
the fractions and not to their toxicity. Therefore, a  toxicity assay was carried out on 
the extracts from region B2 and region B2E. Different concentrations of pure AFBi 
were used as positive controls (Figures 4.20 and 4.21). As it can be observed in 
Figures 4.22 and 4.23, both extracts (B2 and B2E) did not have a toxic effect on both 
tester strains. These results suggested that the anti-mutagenic activity of these 
extracts was due to other factors than their potential toxicity.
5.- Fractionation of B2E (TLC 3)
The thin layer chromatography step 3 o f the isolation process had as an 
objective to fractionate the materials or compounds contained in region B2E. At this 
point, it was considered that after three thin layer chromatography steps, part o f the
102
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Figure 4.22.- Toxicity potential of fractions B2 and B2E on Salmonella tester strain TA98 with metabolic activation. Values
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Figure 4.23.- Toxicity potential of fractions B2 and B2E on Salmonella tester strain TA100 with metabolic activation. Values
are means of three replicates.
initial amount of the active compounds present in the com extract might be lost. This 
could affect the intensity of the anti-mutagenic response to such a degree that it 
could have be not detected. To compensate this loss, the isolation process was started 
(from TLC 1) with a volume of extract equivalent to 120 g of com. After the two 
previous TLC steps, fraction B5 was subjected to a third isolation step (TLC 3) using 
chloroform-acetone (15:1). The TLC 3 procedure was identical to TLC1.
After TLC 3 was performed, six regions could be determined, even though 
resolution was not good enough to describe single bands within this regions. The 
identified region were: B2E1 (Rf = 0.0 - 0.061), B2E2 (Rf = 0.061 - 0.306), B2E3 
(Rf = 0.306 - 0.533), B2E4 (Rf = 0.533 - 0.644), B2E5 (Rf = 0.644 - 0.846), and 
B2E6 (R f = 0.846 - 1.00). The material contained in each one of these regions was 
spiked with AFBi as in previous isolation steps (TLC 1, TLC 2), and tested for anti- 
mutagenic activity. Results are shown in Figures 4.24 and 4.25 for tester strain 
TA98 and TA100, respectively.
The extracts from region B2E1 and B2E5 showed little anti-mutagenic 
response with TA98 and in the TA100 tester strain did not have an effect on AFBi 
mutagenicity. The extract from B2E6 showed a dose-response type of relationship; 
however, it did not show great potency at the highest concentration. The extracts 
from region B2E2, B2E3 and B2E4 showed strong anti-mutagenic responses; B2E3 
and B2E4 behave almost in a parallel way up to the third dilution and were more 
potent than B2E2. These three regions lowered the number of revertants per plate to 
the number o f spontaneous revertants and were very consistent in both tester strains.
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Figure 4.24.- Anti-mutagenic potential of chromatographic regions obtained from TLC fractionation of B2E using
Salmonella tester strain TA98 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng
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Figure 4.25.- Anti-mutagenic potential o f chromatographic regions obtained from TLC fractionation of B2E using 
Salmonella tester strain TA100 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng 
A F B ,/p la te . Pure AFB, control (500 ng/p late) caused  1316 revertants/plate. V alu es are m eans o f  three replicates.
1 Obtained form TLC 2
Regions B2E2, B2E3 and B2E4 were selected for the next isolation 
procedure. However, due to the lack o f resolution, during the last TLC, this 
chromatography was repeated with better resolution. The regions already selected 
(B2E2, B2E3 and B2E4), showed new bands that were also analyzed. The profile of 
the “second TLC 3” is shown in Table 4.2. Since at this step the TLC achieved a 
high degree o f resolution and isolation, the term Band replaced the term Region. All 
these bands were extracted and prepared for the anti-mutagenesis assay as usual. 
Again both Salmonella tester strains TA98 and TA100 were used with metabolic 
activation.
Table 4.2.- Profile o f second TLC 3 plate denoting fractionation o f B2E2, B2E3 and 
B2E4.
Region Bands contained (Rf) Description
Label (Rf)








B2E3 (0.30-0.53) B2E3A (0.33)






B2E4 (0.53 0.64) B2E4A (0.55) yellow-greenish
Results o f  the anti-mutagenesis assay performed on these eight bands are 
shown in Figures 4.26 - 4.31. As can be observed in Figures 4.26 and 4.27, bands 
B2E2B, B2E2C, and B2E2D showed similar behavior. All o f them were considered 
non anti-mutagenic. On the contrary, B2E2A was consistent in showing a dose- 
response type o f relationship being more potent with tester strain TA98.
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Figure 4.26.- Anti-mutagenic potential of bands included in B2E2 using Salmonella tester strain TA98 with metabolic
activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB, control (500 ng/plate)
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Figure 4.27.- Anti-mutagenic potential of bands included in B2E2 using Salmonella tester strain TA100 with metabolic
activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB, control (500 ng/plate)
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Figure 4.28.- Anti-mutagenic potential of bands included in B2E3 Salmonella tester strain TA98 with metabolic activation.
Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB, control (500 ng/plate) caused 559
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Figure 4.29.- Anti-mutagenic potential of bands included in B2E3 using Salmonella tester strain TA100 with metabolic
activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB, control (500 ng/plate)
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Figure 4.30.- Anti-mutagenic potential o f band included in B2E4 using Salmonella tester strain TA98 with metabolic
activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB, control (500 ng/plate)
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Figure 4.31.- Anti-mutagenic potential o f band included in B2E4 using Salmonella tester strain TA100 with metabolic
activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB, control (500 ng/plate)
caused 1872 revertants/plate. Values are means of three replicates.
Results (Figures 4.28 and 4.29) for bands B2E3A, B2E3B, and B2E3C were 
highly consistent for both strains. B2E3A failed to show any anti-mutagenic 
response while B2E3B and B2E3C behave almost in a parallel pattern. These two 
bands lowered the number of revertants per plate to the number o f spontaneous 
revertants at their highest concentration. Finally, B2E4A was a mere confirmation of 
the previous anti-mutagenic assay result (Figures 4.30 and 4.31). At the end of this 
assay, bands B2E2A, B2E3B, B2E3C, and B2E4A were selected for the next step in 
the isolation process.
6.- Fractionation of B2E2A, B2E3B, B2E3C, and B2E4A (TLC 4)
The individual fractionation (TLC 4) o f  the extracts from bands B2E2A, 
B2E3B, B2E3C and B2E4A was performed following the same chromatographic 
procedure as in TLC 1 and TLC 3. To compensate the loss o f  material by the four 
TLC procedures, the volume of extract equivalent to 200 g o f com was used to 
initiate the isolation process. After fractionation, every individual TLC 4 plate 
produce a  different profile. TLC plate profiles from the fractionation of bands 
B2E3B, B2E3C and B2E4A are summarized in Tables 4.3, 4.4, 4.5, and 4.6, 
respectively. After fractionation, the resulting bands were extracted and prepared as 
usual for the anti-mutagenesis assay. The band B2E2A was fractionated into 2 bands, 
B2E2A1 and B2E2A2.
Even though the highest concentration of B2E2A1 showed anti-mutagenic 
activity relative to the first dilution on tester strain TA100, this was not consistent for 
the other tester strain. B2E2A2 failed in both tester strains to this test and both bands
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were considered non anti-mutagenic (Figures 4.32 and 4.33). For the bands obtained 
from the fractionation of B2E3B, only B2E3B5 and B2E3B6 showed a consistent 
dose-response type of relationship in both tester strains. The rest of the bands behave 
differently with each tester strain (Figures 4.34 and 4.35). Because B2E3B5 showed 
higher potency, it was selected for further studies. Among the bands obtained from 
B2E3C, band B2E3C2 and B2E3C3 were selected for their consistency in showing a 
nice dose-response in both tester strains (Figures 4.36 and 4.37). In the same way, 
among the bands obtained from B2E4A, only B2E4A4 and B2E4A5 showed anti- 
mutagenic response in both strains in a consistent manner.
Table 4.3.- Profile of the fractionation of B2E2A after TLC 4.
Band Description
Label (Rf)
B2E2A1 (0.06) diffuse blue
B2E2A2 (0.10) diffuse blue
However, B2E4A4 was selected for further studies because it showed almost 
a linear dose-response (Figures 4.38 and 4.39). Summarizing this last step in the 
isolation process, bands B2E3B5, B2E3C2, B2E3C3, and B2E4A4 showed the best 
anti-mutagenic activity behavior and were selected for further instrumental analysis.
In summary, com contaminated with high (450 ppb) amounts o f AFBi was 
found not to show the mutagenicity that same amount of pure AFBi usually cause in 
the Ames test. To demonstrate the presence o f anti-mutagenic compounds in com, 
pure AFBi was added to clean com extracts and they were tested for mutagenicity. 
They failed this test. The existence o f anti-mutagenic factors in com was suggested.
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Figure 4.32.- Anti-mutagenic potential of bands obtained after TLC fractionation of B2E2A using Salmonella tester strain
TA98 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB,
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Figure 4.33.- Anti-mutagenic potential of bands obtained after TLC fractionation B2E2A using Salmonella tester strain
TA100 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB,
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Figure 4.34.- Anti-mutagenic potential o f bands obtained after TLC fractionation of B2E3B using Salmonella tester strain
TA98 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB,
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Figure 4.35.- Anti-mutagenic potential of bands obtained after TLC fractionation of B2E3B using Salmonella tester strain
TA100 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB,
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Figure 4.36.- Anti-mutagenic potential of bands obtained after TLC fractionation of B2E3C using Salmonella tester strain
TA98 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB,
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Figure 4.37.- Anti-mutagenic potential of bands obtained after TLC fractionation of B2E3C using Salmonella tester strain
TA100 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB,







































Figure 4.38.- Anti-mutagenic potential of bands obtained after TLC fractionation of B2E4A using Salmonella tester strain
TA98 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB,
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Figure 4.39.- Anti-mutagenic potential of bands obtained after TLC fractionation B2E4A using Salmonella tester strain
TA100 with metabolic activation. Every sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Pure AFB,
control (500 ng/plate) caused 3976 revertants/plate. Values are means of three replicates.
Table 4.4.- Profile o f the fractionation of B2E3B after TLC 4.
Band Bands contained (Rf) Description
Label (Rf)
B2E3B1 (0.14) - yellow
B2E3B2 (0.22) - strong blue, abundant
B2E3B3 (0.28-0.38) 1st band (0.2843) 
2nd band (0.3) 







B2E3B4 (0.46) - light blue
B2E3B5 (0.48) - strong, bright, green
B2E3B6 (0.54) - very light
Table 4.5.- Profile o f the fractionation of B2E3C after TLC 4.
Band Bands contained (Rf) Description
Label (Rf)
B2E3C1 (0.1779) - very light blue
B2E3C2 (0.45-0.50) 1st band (0.46) 
2nd band (0.49)
diffuse, wide, blue 
strong yellow
B2E3C3 (0.55) - light blue
Table 4.6.- Profile o f the fractionation of B2E4A after TLC 4.
Band Description
Label (Rf)
B2E4A1 (0.082) very narrow and light yellow
B2E4A2 (0.141) vanishing blue
B2AE43 (0.184) yellowish
B2E4A4 (0.543) very strong and bright yellow
B2E4A5 (0.590) narrow and light yellow
B2E4A6 (0.650) very light blue
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Since AFBi spiked clean com did not showed mutagenicity, it was also 
suggested that the anti-mutagenic factors were intrinsic to the com nature and not to 
mold residues or metabolites. These finding were consistent with results obtained by 
Weng et al. (1997). While studying the mutagenic potential of ammonia/aflatoxin 
reaction products, they also found that com containing extremely high (7500 ppb) 
amounts o f AFBi failed the mutagenicity assay.
Weng et al. (1997) also suggested that these "unknown interfering material" 
chromatographed with AFBi under the same conditions used during TLC 1. The 
present study, demonstrated that bands obtained from region B2 (where AFBi was 
found after TLC 1) showed outstanding dose-response relationship when their 
concentration varied against a constant amount o f AFBi. At this point, it was 
important to demonstrate that the decrease in the number of revertants/plate was due 
to the anti-mutagenic compounds present in the com and not to toxicity produced by 
the com extracts. The toxicity assay performed on both tester strains and using B2 
(from TLC 1) and B5 (from TLC 2), the fractions with lower level o f purity showed 
no toxic effect from these extracts to bacteria.
Finally, after four chromatographic steps, bands with very consistent and 
strong anti-mutagenic activity were identified. Localization on the TLC plate, 
developing conditions and optical aspect o f the bands were determined. However, 
what is important to mentioned is that, there are a number of compounds that were 
left behind in the isolation procedure. These compounds, possibly with less potency, 
may act sinergistically with those found in the most isolated extracts.
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However, it was impossible to developed and isolate every single band that 
showed signs o f anti-mutagenic activity. Anti-mutagenic bands had to be 
discriminated by showing features such as dose-response type o f relationship, 
potency, graphical slop, and consistency in activity in both tester strains. These anti- 
mutagenic isolates will be used in further studies.
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CHAPTER 5. PARTIAL CHARACTERIZATION OF ANTI-MUTAGENIC
COMPOUNDS FROM CORN
I.- Rationale
In this study, com fractions obtained from the isolation process o f anti- 
mutagenic factors (CHAPTER 4) were subjected to several analyses. The anti- 
mutagenic activity of these fractions was tested against l-methyl-3-nitro-l- 
nitrosoguanidine (MNNG), a direct acting mutagen. The com fractions were exposed 
to two concentration of this agent and tested for anti-mutagenicity in the Ames test 
using Salmonella tester strain TA100 with no metabolic activation (S9). All the com 
fractions tested showed evidence of anti-mutagenic activity by producing a dose- 
response relationship between a constant amount of MNNG and several 
concentrations o f tested com fraction. Five different varieties of yellow com were 
tested for anti-mutagenic activity in order to know whether the anti-mutagenic 
factors were intrinsic to the com nature. All com varieties showed anti-mutagenic 
activity in the Ames test. Four com fractions obtained after the isolation process 
were analyzed by MALDI-MS and GC-MS. MALDI-MS showed the presence of 
two groups o f molecules or molecular fragments. The molecular mass of one group 
ranged from 250 to 370 m/z, the other ranged from 540 to 640 m/z. GC-MS showed 
the possible presence o f a linoleic acid-like compound in one of the analyzed com 
fractions.
II.- Introduction
The existence of materials in com that interfere with the mutagenic potential of 
AFBi in the Ames test has been reported by Weng et al. (1997). While studying the
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mutagenic potential of aflatoxin/ammonia reaction products, they observed that highly 
aflatoxin-contaminated com extracts were not mutagenic; however, same amounts of 
pure AFBi were mutagenic. These observations were consistent with previous studies 
(Lee et al., 1984; Lawlor et al., 1985; Haworth et al., 1989).
Weng et al. (1997) attempted to separate this interfering material from the com 
matrix using preparative thin layer chromatography (TLC) in silica gel. They identified 
the band corresponding to AFBi; they extracted it form the silica and tested it for 
mutagenesis. Unexpectedly, the extract containing AFBi also failed to show mutagenic 
response. Based on these results, they concluded that the interfering materials migrated 
together with AFBi and, therefore, AFBi was inhibited in the Ames test. These 
interfering materials were not isolated or identified.
In the previous study (CHAPTER 4), com extracts were subjected to several 
TLC procedures. Consistent with the findings of Weng et al. (1997), anti-mutagenic 
activity was observed in the region were AFBi was found. However, after the second 
TLC, these anti-mutagenic factors were separated from AFBi. Along the isolation 
procedure, several anti-mutagenic isolates that showed variable anti-mutagenic 
potential. In this study, the third and last part of this project, four anti-mutagenic 
isolates obtained in the previous study were selected for different tests and analyses for 
their partial characterization.
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III.- Materials and Methods
1.- Chemicals
D-biotin, L-histidine, ampicillin, tetracycline, sodium dihydrogen phosphate, [3- 
nicotinamide adenine dinucleotide phosphate (NADP, sodium salt), and glucose-6- 
phosphate were purchased from Sigma-Aldrich, St. Louis, MO. Citric acid 
monohydrate, potassium phosphate, dibasic, anhydrous, potassium chloride, 
chloroform, methylene chloride, methanol, dimethyl sulfoxide, and water (HPLC 
grade) were purchased from Mallinckrodt Baker, Inc., Paris, Kentucky. Magnesium 
chloride was purchased from Baker Inc., Phillipsburg, NJ. Disodium hydrogen 
phosphate and sodium chloride were purchased from EM Science, Cherry Hill, NJ. 
Bacto agar and crystal violet were obtained from Difco-Laboratories, Detroit Michigan. 
Glucose was purchased from Fisher Scientific, Fair Lawn, NJ. Acetonitrile was 
purchased from Baxter, Muskegon, M3. Acetone was obtained from Chempure, 
Houston, TX. Post mitocondrial supernatant was obtained from Molecular Toxicology, 
Inc., Boone, NC. Aflatoxin Bi standard was provided by Dr. Mary W. Trucksess.
2.- Corn Samples
Clean and naturally aflatoxin-contaminated com was obtained from Texas, 
kindly provided by Dr. Jeff Ellis, Texas Office of the State Chemist. These samples 
were labeled and stored in plastic bags at 4°C. Several samples of different varieties of 
clean com were kindly provided by Dr. Manjit S. Kang, Department of Agronomy, 
Louisiana State University Agricultural Center. These samples were immediately 
ground and extracted for further analysis.
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3.-Preparation of Corn Extracts
All com samples were ground in a Brinkman Retsch mill, type ZM 1, model 
65297, to pass a No. 1.0 Brinkman Retsch mill screen. In order to prepare the com 
extracts, four portions of 100 grams of ground com were placed inside 1000 mL 
Erlenmeyer flasks and 500 mL methylene chloride were added to everyone. All the 
flasks were shaken for 30 min using a wrist action shaker (Burrell Wrist Action Shaker, 
model 75, Pittsburg, PA), at speed grade 2. The mesh from each flask was filtered 
through a Whatman No. 4 filter paper under vacuum. The filtrate (approximately 450 
mL) was combined with the others and concentrated to approximately 20 mL using a 
rotavapor (Brinkman Buchi rotavapor, model RE121, Switzerland) at 37 C and rotated 
at 60 rpm. The com extract was finally adjusted to 25 mL with methylene chloride and 
stored at 4°C for further use.
4.- Anti-mutagenicity Determination
The determination of anti-mutagenicity activity towards AFBi in the com 
extracts was carried out using the Salmonella microsomal mutagenicity assay (Ames 
test) described by Maron and Ames (1983).
The dry extracts, obtained either directly from com or from thin layer 
chromatography fractionation of com extracts, were reconstituted and diluted (0, 5, 25, 
125 and 625 times) with dimethyl sulfoxide (DMSO). At the same time, every single 
dilution was spiked with either pure AFBi or MNNG to a final concentration of 500 ng 
(500 and 1000 ng for MNNG) of mutagen/100 pL of diluted extract. These solutions 
were then assayed using the plate incorporation procedure of the Ames test. Briefly,
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100 pL o f sample were combined with 100 pL of bacterial culture (both, Salmonella 
tester strains TA98 and TA100 were used) and 500 pL of S9 mix into a test tube 
containing 2.0 mL of top agar. This mixture was poured onto minimal glucose agar 
plates and incubated at 37°C for 48 hours. The number o f revertants were manually 
obtained using a Bactrovic colony counter, model C-110, New Brunswick Scientific 
Co., New Brunswick, N.J., and compared against a standard curve. The standard curve 
was obtained for both tester strains using different AFBi concentrations. Biochemical 
tests on the histidine requirement, rfa mutation, and R-factor, were conducted every 
time the Ames test was performed. All the assays were carried out in triplicate.
Protocol for the Handling of MNNG
Due to the extremely hazardous character of MNNG, a special protocol was 
designed and followed for its handling before, during, and after the anti-mutagenicity 
assay were this compound was involved. The MNNG container was opened only within 
a biological laminar flow hood and wearing the appropriate Personal Protective 
Equipment (PPE) such as body suits, double nitrile-gloves, organic vapor-respirator and 
safety goggles.
1.- All the material and equipment used to weight the MNNG had to be placed on a 
water-wetted surface (i.e., paper towel) and all the glassware used was disposed.
2.- The MNNG was extracted from the container with a small metallic spatula and 
deposited inside o f a flask. This flask was pre-placed on a scale previously covered with 
wet filter paper. In case o f any spill, MNNG (a water soluble compound) could stick to 
the protective wet surfaces. After use, the spatula was wiped with a wet towel.
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3.- An appropriate pre-measured volume of DMSO was poured into the flask to make 
the required MNNG solution. After the MNNG container was closed and the solution 
prepared, the secondary pair of gloves was changed for a new pair.
4.- From the MNNG solution (stock solution) necessary dilutions were made using 
disposable pipettes and glass vials. After the required diluted solution was prepared, a 
secondary pair of nitrile-gloves was changed again.
5.- With the diluted MNNG solution, the testing samples were spiked using disposable 
pipettes and they were left inside the hood for the test.
6.- After the samples were spiked all the material and equipment was wiped with wet 
towels and taken out from the hood. All the material was deposited into a biohazard 
waste disposal cardboard box.
7.- The Same PPE was worn during the anti-mutagenicity assay.
8.- After the assay was completed, all vials containing the spiked sample were disposed 
and autoclaved. Autoclaved waste was turned to the LSU Campus Safety Office 
personnel for appropriate disposal. MNNG was put securely in a secondary container, 
appropriately labeled, and stored at -20°C for further use.
5.- Spectrometry Analysis
TLC bands that were selected for spectrometry analysis were scraped from the 
TLC plate and extracted with 50 mL (twice with 25mL) chloroform-acetone-methanol 
(8:1:1) and filtered through Whatman No. 4 filter paper. The extracts were evaporated 
to dryness under N2 stream and stored at -20°C until analyzed. Samples were analyzed 
at the LSU Mass Spectrometry Facility.
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Gas Chromatography / Mass Spectrometry (GC/MS)
The dry samples were dissolved in 1 mL dimethyl chloride (CH2CI2) and 1 |uL 
of this solution was injected into a 0.22mm (diameter) x 25 m (length) 5.0% phenyl 
polysiloxane SGE gas-chromatography column incorporated into a Hewlett Packard 
5890 Series II Gas Chromatograph coupled to a Hewlett Packard 5971A Mass Selective 
Detector were fractions firom GC were analyzed spectrometrically. Gas 
chromatography was carried out using He, as gas carrier, with a retention time of air = 
1.14 min, linear flow velocity = 26.6 cm/sec, volumetric flow rate = 0.83 mL/min, and 
total flow = 50 mL/min. The spectra obtained were compared to a spectra library using 
the Wiley Data Base.
Matrix Assisted Laser Desorption/Ionization (MALDD
Samples were also dissolved in 1 mL CH2CI2 and 0.5 fiL was combined with 
1.0 pL of 2,5-dihydroxybenzoic acid (gentisic acid, MW = 154). A Voyager™ Maldi 
TOF (Time-of-Flight) Mass Spectrometer (BioSpectrometry™, Workstation) was 
used to analyzed the samples. Laser power was set at 290 and the average of scans 
were varied with the sample.
IV.-Results and Discussion
As reported in CHAPTER 4, anti-mutagenic isolates were obtained from the 
TLC fractionation of aflatoxin-free and AFBi-contaminated com extracts. These 
isolates which were obtained at different stages of the isolation process always showed 
anti-mutagenic activity regardless of the degree of purity. This chapter describes the 
research conducted to determine additional toxicological properties of these anti-
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mutagenic isolates as well as partial chemical characterization. Questions addressed 
included: Are these mutagenic factors present in multiple com samples? Are they active 
against mutagens other than AFBi? What are some of the chemical characteristics o f 
these compounds? To answer these questions, several tests and instrumental analyses 
were performed. Until now, these compounds remained “unknown interfering 
materials” as described by Weng et al. (1997). In the current study, a procedure for the 
isolation o f active fractions from com was followed which identified several 
compounds and factors (such as the oily character of B3 band from TLC 1) that have 
and effect on the anti-mutagenic potential to AFBi. The initial characterization of these 
fractions or isolates was accomplished through this process.
1.- Determination of Anti-mutagenic Activity in Different Corn Varieties
Efforts were conducted to determine if these anti-mutagenic compounds 
isolated previously were present in other com varieties different from our samples. 
The presence o f anti-mutagenic potentials in five com samples from five different 
varieties was determined. The variety name and sample code used to identified them 
during this study are presented in Table 5.1. Isolates were obtained from each com 
sample by CH2CI2 extraction and TLC 1 fractionation procedure. The region B2 
from TLC 1 was obtained for each sample and analyzed for anti-mutagenicity using 
the Salmonella / microsomal mutagenicity assay using both Salmonella tester strains 
TA98 and TA100 with metabolic activation. The region B2 was selected for this 
assay for two reasons: (1) this region was already demonstrated to include the anti-
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mutagenic isolates at the end of the isolation process, and (2) by testing B2, the
effect of the fat from B3, which may vary among the varieties, was avoided.
Table 5.1.- Different varieties o f com tested for anti-mutagenic activity in the Ames 
test.






Extracts obtained from region B2 from each com variety were dissolved and 
diluted in DMSO and every dilution was spiked with AFBi to provide 500 ng of 
toxin /plate in the test. Results from the anti-mutagenicity assay performed on these 
com samples are shown in Figures 5.1 and 5.2 for TA98 and TA100, respectivley.
Anti-mutagenic activity was observed in all com varieties tested. All showed
uniform dose-response type o f relationship and reduced the number of revertants
caused by 500 ng o f AFBi per plate to the spontaneously revertant rate. The slope of
the anti-mutagenic response was very similar for all samples tested. This pattern was
consistent for both tester strains. These results suggest that the anti-mutagenic
isolates was present in all com varieties tested. From this, it is assumed that the
compounds responsible for the anti-mutagenic activity in com, may be intrinsic to
com naturally. Only yellow com was used throughout this research, however.
2.- Anti-mutagenic Activity Against l-methyl-3-nitro-l-nitrosoguanidine 
(MNNG)
The anti-mutagenic activity of the isolates obtained from com were 
demonstrated to decrease or inhibit the mutagenic activity of AFBi in the present
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Figure 5.1.- Anti-mutagenic potential of five different varieties of yellow com using Salmonella tester strain TA98
with metabolic activation. The analyzed extracts correspond to the B2 fraction from each com sample. Every
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Figure 5.2.- Anti-mutagenic potential of five different varieties o f yellow com using Salmonella tester strain TA100
with metabolic activation. The analyzed extracts correspond to the B2 fraction from each com sample. Every
sample dilution was spiked with AFB, to provide 500 ng AFB,/plate. Values are means of three replicates.
study as well as the active materials named “anti-aflatoxin factors” by Weng et al. 
(1997). In this phase o f  the study, the anti-mutagenicity o f the isolates was tested 
against a direct acting mutagen (i.e., does not require metabolic activation) 1-methyl- 
3-nitro-l-nitrosoguanidine (MNNG) using the Salmonella / microsomal mutagenicity 
assay with tester strain TA100, with and without S9 (Maron and Ames, 1983). 
MNNG has been identified as a highly potent mutagen in the absence of S9. This 
mutagen has been reported to be a extremely hazardous compound (Maron and 
Ames, 1983), therefore, special safety measures were taken for the performance of 
this experiment using MNNG.
Safety Measures for the Handling of MNNG
Due to risks posed by MNNG, special safety measures recommended by the 
LSU Campus Safety Office were followed, which included (1) restricted access to 
the laboratory where MNNG was going to be used during the time the test was 
conducted; (2) only safety trained researchers were allowed to handle MNNG; (3) 
workers had to wear appropriate personal protective equipment that included body 
suits, double nitrile-gloves, organic vapor-respirator and safety goggles; (4) the assay 
should be limited to one tester strain and using the minimum o f samples possible in 
order to shorten the time of exposure; and (5) all the waste (material, chemical, and 
biological) produced from this experiment should be properly labeled and disposed 
by LSU Campus Safety Office Personnel. For the assay involving the use of MNNG, 
a special protocol was designed and followed. This protocol is detailed in the section 
on materials and methods for this chapter.
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Anti-mutagenicitv Test Using MNNG
In addition to results reported in the scientific literature about the metabolic 
activation requirements for MNNG, the mutagenicity of this compound was 
confirmed using Salmonella tester strain TA100 with and without S9 in this study 
(Figure 5.3). The results were consistent with those reported in the literature. MNNG 
showed a mutagenic response with exposure to 100 ng of this compound per plate. 
This response was similar with and without S9 bioactivation. This confirmed that 
MNNG did not require biotransformation to a reactive metabolite in order to be 
mutagenic. These data permitted the conduction of anti-mutagenicity assays in the 
absence of S9.
For the anti-mutagenicity assay, the bands B2E2A, B2E3B, B2E3C, and 
B2E4A were obtained after fractionation step TLC 3, extracted, dissolved, and 
diluted in DMSO. Each single dilution was spiked with MNNG to provide 500 ng of 
this compound per plate. As evident in Figure 5.4, all the bands tested showed anti- 
mutagenic activity. It was observed, however, that the spiking level was not high 
enough to observe a very defined response. For example, band B2E2A response did 
not change very much along its dilutions; even though a slope from the most 
concentrated dilution to the fourth was observed, indicating minimal evidence of 
anti-mutagenic activity. On the other hand, band B2E4A showed a very defined 
dose-response relationship along its dilutions, clearly indicating an anti-mutagenic 
activity. These results were not considered strong enough evidence of anti­
mutagenicity. According to Maron and Ames (1983), MNNG usually fails do
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Figure 5.3.- Standard curve for the mutagenic potential of 1-methyl-3-nitro-l-nitrosoguanidine (MNNG) using Salmonella
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Figure 5.4.- Anti-mutagenic potential of bands B2E2A, B2E3B, B2E3C, and B2E4A using Salmonella tester strain TA100
without metabolic activation. Every sample dilution was spiked with MNNG to provide 500 ng MNNG/plate. MNNG control
(500 ng/plate) caused 278 revertants/plate. Values are means of three replicates.
produce linear dose-response effects in this assay; however, in the current study, the 
standard curve observed for this compound (Figure 5.3) a uniform dose-response 
was evident. Therefore, it was decided to repeat this assay using a higher spiking 
level.
For the second trial, sample dilutions were spiked with 1000 ng of 
MNNG/plate. A well defined dose response curve was observed for B2E3B and 
B2E3C (Figure 5.5). However, band B2E4A failed to show this kind of response 
during this particular assay and the sample corresponding to B2E2A was lost. The 
results obtained from the two anti-mutagenicity assays carried out for the four bands 
indicated that bands B2E3B and B2E3C had an anti-mutagenic effect against 
MNNG. Even though B2E4A showed low anti-mutagenic activity at the low spiking 
level assay, it did not respond in the second assay. Therefore, this was not considered 
enough evidence to suggest the anti-mutagenicity o f B2E4A against MNNG. 
However, some unidentified error in the performance of the anti-mutagenicity assay 
for B2E4A was possible; therefore, the possibility of B2E4A still being active 
against MNNG exists and it is supported by data obtained in the first anti­
mutagenicity assay carried out at low spiking level. The same explanation was given 
for the anti-mutagenicity o f B2E2A which was not tested in the second assay.
The anti-mutagenic effect of isolates found active against MNNG, a direct 
actively mutagen, in this experiment suggests that the mechanism o f action of the 
active compounds found in these bands may be the direct interaction with theAFBi. 
When AFBi was evaluated in the anti-mutagenicity test, data did not permit the
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Figure 5.5.- Anti-mutagenic potential of bands B2E3B, B2E3C, and B2E4A using Salmonella tester strain TA100 without
metabolic activation. Every sample dilution was spiked with MNNG to provide 1000 ng MNNG/plate. MNNG control (1000
ng/plate) caused 1825 revertants/plate. Values are means of three replicates.
determination o f whether the anti-mutagens were acting directly on the reactive 
metabolite or on the metabolizing enzymes (S9). Since AFBi requires metabolic 
activation prior to exhibiting mutagenic potential, it is possible that the interaction of 
the anti-mutagens with the S9 could inhibit the metabolizing enzymes responsible for 
the transformation o f AFBi to the reactive metabolite, AFBi-8,9-epoxide. However, 
during the anti-mutagenicity assay using MNNG as the mutagen, the S9 is absent; 
therefore, it is possible that the mechanism of action of these anti-mutagens is to 
inhibit one or more of the events that occur between the exposure o f the bacteria to 
the mutagen and the actual mutation o f bacterial DNA. One of the mechanism that 
would fit this hypothesis is the direct blockade of the mutagen by the anti-mutagen. 
Further analysis with an enzyme inhibition assay would have to be conducted in 
order to be able to discount the possibility o f  the interaction of the anti-mutagen with 
the S9. With this type of assay, the inhibitory properties o f the anti-mutagens on the 
activity o f the metabolizing enzymes could be evaluated.
3.- Mass Spectrometry Analysis
The final isolates B2E3B5, B2E3C2, B2E3C3, and B2E4A4 were selected 
for structural elucidation through instrumental analysis. Samples were obtained after 
the isolation step TLC 4 (Figure 4.2). Each isolate was extracted from the preparative 
TLC plate, dissolved in CH2CI2, and analyzed spectrometrically using a Matrix 
Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI-MS) and Gas 
Chromatography / Mass Spectrometry (GC-MS) techniques.
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The isolates were mixed with dihydroxybenzoic acid and analyzed by 
MALDI-MS. Spectrograms obtained from these analysis are shown in Figures 5.6 -  
5.9. In these spectrograms a number of peaks were observed; high density peaks 
appeared first at 100-200 m/z which corresponded to dihydroxybenzoic acid (the 
matrix used in this analysis). The peaks that appeared between 500- 640 m/z were 
postulated to be associated with ionized molecules o f the compounds present in the 
test isolates. Peaks appearing in the median range (250-450 m/z) may be fragments 
from the compounds in the sample or molecules o f lower molecular mass present 
also in the isolates. These results may indicate that the compounds responsible for 
the anti-mutagenic activity in com have a molecular mass between 200 - 640 m/z.
For GC-MS, the isolates were dissolved in CH2CI2 and injected on the GC 
column for separation and mass spectral analysis. The spectrograms corresponding to 
B2E3B5, B2E3C2, B2E3C3, and B2E4A4 are shown in Figures 5.10, 5.11, 5.12, and 
5.13, respectively. The spectrogram for the band B2E3B5 showed that this isolate 
either still contained a large number of low molecular weight compounds or that the 
isolated compounds produced numerous. The spectrograms for the remaining 
isolates showed a greater degree of purity, in particular isolates B2E3C2 and 
B2E4A4). These results showed that a common compound or fragment was present 
in B2E3B5, B2E3C3, and B2E4A4 with a retention time of 11.34 min. This 
compound or molecule fragment had the greatest intensity. The spectrum of this peak 
was compared to a library of spectra using the Wiley Data Base to locate a matching 
spectrum that could indicate a possible structural identity. This molecule or molecule
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fragment had an 83% quality matching with phenol (l,l-dimethylethyl)-4-methoxy- 
moiety which has a molecular with o f 180 and its empirical formula is C 11H 16O2 .
The spectrogram for isolate B2E3C2 showed a very high and pure peak with 
a  retention time of approximately 15.335 min. This peak was compared to a spectra 
library where the spectrum corresponding to 9,12-octadecadienoic acid (linoleic 
acid) had a quality match of 93 % (Figure 5.14). This is strong evidence that the 
biologically active agent in this isolate is structurally similar to linoleic acid or a 
linoleic acid-like compound.
The anti-mutagenic properties o f linoleic acid have been studied previously. 
Aikawa and Komatsu (1987) reported that linoleic and oleic acids inhibited 
mutagenesis in Escherichia coli B/r WP2 and WP2 uvrA induced by irradiation with 
ultraviolet light. Aikawa (1988), in another study, found the same anti-mutagenic 
activity when he tested linoleic acid against 2-aminofluorine using Salmonella tester 
strain TA98 with metabolic activation. More recently, conjugated linoleic acid, 
together with other cow’s milk fat components, has been found to have 
anticarcinogenic properties. Conjugated linoleic acid has been found to inhibit 
proliferation of human malignant melanoma, colorectal, breast and lung cancer cell 
lines. In animals, it reduced the incidence o f chemically induced mouse epidermal 
tumors and mouse forestomach neoplasia. At close to physiological concentrations, 
conjugated linoleic acid has been found to inhibit mammary tumorigenesis (Parodi, 
1997). In addition, linoleate has been found to inhibit the protumor-promoting action 
o f  arachidonate in mouse skin carcinogenesis (Fischer et al., 1996).
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Figure 5.14.- Spectral analysis (GC/MS) of the peak with retention time 15.335 min from isolate B2E3C2 compared to 
spectra library using Wiley Data Base.
The information available on the protective properties o f linoleic acid against 
mutagenic and carcinogenic events supports the possibility that the compound 
ormolecule fragment found in isolate B2E3C2 was a linoleic acid-like compound 
that also has anti-mutagenic activity against AFBi and MNNG. Further studies are 
required to confirm the exact identity of this compound fragment. It is important, 
however, to point out that peaks obtained from MALDI-MS analysis at a molecular 
mass ranging from 500-640 m/z might correspond to molecules of similar molecular 
weight such as, triglycerides, phopholipids, phosphatidylcholine, 
phosphatidylethanolamine, phosphatidylinositol, that, may contain linoleic acid in 
their molecules and also are present in com (Weber, 1983).
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CHAPTER 6. SUMMARY AND CONCLUSIONS
Aflatoxin contamination is a worldwide problem that has persisted since 
aflatoxins were discovered. Chronic exposure to aflatoxin-contaminated 
commodities has been related to the induction of primary hepatocellular carcinoma. 
The mutagenicity, carcinogenicity, teratogenicity, and acute toxicity of AFBi is well 
documented. Prevention is the best way to avoid aflatoxin contamination; however, 
if  contamination is evident measures must be taken to reduce the risk associated with 
the presence of aflatoxins in food and feeds. Therefore, several methodologies for 
the decontamination o f aflatoxin affected commodities have been developed. These 
methods are based on physical, biological, and chemical principles.
Among the chemical decontamination procedures, ammoniation has been 
demonstrated to be one of the most effective procedures. This process involves the 
treatment of contaminated com with ammonia compounds or gaseous ammonia, high 
temperatures, and high pressures. A low temperature / low pressure ammoniation 
process is also used; however, this process takes longer to achieve the same 
decontamination levels (>99%) than the former procedure. The fermentation of 
aflatoxin-contaminated com, previously treated with ammonia, has been studied. 
These processes have demonstrated that fermentation does not affect the 
decontamination o f com and that ammoniation does not affect ethanol production. 
Base on these data, the decontamination of aflatoxin-containing com during the 
fermentation process may produce fuel alcohol and decontaminated distillers’ dried 
solids grains that may be used for animal feed.
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As previously mentioned, one of the objectives o f this project was to study 
the effect o f ammonium persulfate and three different peroxides on the 
decontamination of AFBi-containing com and the ethanol production during an 
integrated fermentation process. Naturally AFBi-contaminated (144 ng/g) com was 
fermented following a dry-milling type o f  fermentation procedure. In order to reduce 
the AFBI content in the com, several concentrations of ammonium persulfate (0.25, 
0.50, 0.75, 1.0, 1.5, and 2.0%) were added during this process. The decontamination 
o f naturally AFBi-containing com was demonstrated. Addition of 2.0% ammonium 
persulfate reduced by 87% the level o f AFBi in the fermented com. In addition, the 
ethanol yield was not affected (compared to the control) by the addition o f  
ammonium persulfate.
The effect o f azodicarbonamide, benzoyl peroxide, and hydrogen peroxide on 
the AFBi content o f fermented com and the ethanol production was also studied. 
Two concentrations (0.5 and 1.0%) of these peroxides were added during three 
different stages (liquefaction, saccharification, and fermentation) o f the fermentation 
process. The addition o f either concentration o f azodicarbonamide or hydrogen 
peroxide did not have an effect on ethanol production. Addition of 1.0% of the same 
chemical during saccharification and fermentation significantly decreased the 
ethanol production by 90%. The addition o f 1.0% of these peroxides during the 
fermentation stage significantly affected the detoxification of AFBi in the fermented 
com. However, 0.5% of benzoyl and hydrogen peroxide during fermentation and 
saccharification, respectively, improved decontamination by 10%. From these results
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it was concluded that the use of 2.0% ammonium persulfate and 0.5% benzoyl 
peroxide (during liquefaction and saccharification), produced the best methods for 
the decontamination of AFBi-containing com during fermentation. It was also 
concluded that the use o f 1.0% of any of these chemicals was not suitable for either 
ethanol production or decontamination. None of these treatments were mutagenic. 
However, during this study, a difference in the mutagenic potential o f pure AFBi and 
AFBi as a com contaminant was observed. This observation was previously reported 
by Weng et al. (1997).
The second objective of this study was to isolate the materials responsible for 
the anti-mutagenic activity observed during the first part o f this project. These 
interfering materials were previously reported to migrate together with AFBi during 
thin layer chromatography (TLC). Com extracts were sequentially fractionated using 
TLC. After the first TLC procedure, the region corresponding to AFBi showed an 
anti-mutagenic effect. This result was consistent with previous findings. Several com 
fractions with anti-mutagenic activity against pure AFBi in the Ames test were later 
obtained. These fractions showed a dose-response type o f relationship between com 
extract concentrations and a constant amount o f pure AFBi. After the second TLC 
procedure, anti-mutagenic materials were separated from AFBi. Com extracts were 
shown to be non-toxic to both Salmonella tester strains TA98 and TA100. Based on 
these findings, it was concluded that more that one compound with anti-mutagenic 
activity was present in the com. These compounds had the property o f decreasing the 
mutagenic potential of AFBi in a dose-response type o f relationship. It was also
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observed that these anti-mutagenic compounds differed in their anti-mutagenic 
potentials.
The last part o f this project had as an objective the partial characterization of 
the materials responsible for the anti-mutagenic character of the com extracts. Com 
fractions from five different varieties of com were tested for anti-mutagenic activity 
against pure AFBi. All of these com fractions proved to be active in the Ames test 
using both Salmonella tester strain TA98 and TA100. During the second study, anti- 
mutagenic activity was observed in both AFBi-contaminated com and AFBi-free 
com. These findings suggested that anti-mutagenic materials are intrinsic to the com 
and not to fungi. Com fractions were also tested against a direct acting mutagen, 
MNNG. These fractions inhibited the mutagenicity of MNNG in a dose-response 
type of relationship. This suggested the possibility o f the anti-mutagenic factors 
acting directly on the mutagen or reactive metabolite. However, further studies have 
to be carried out in order to postulate the mechanism o f action o f these anti- 
mutagenic factors. For this purpose, study of the inhibition o f metabolizing enzymes 
activity present in the S9 by these anti-mutagenic fractions is recommended, in order 
to complement the present information. Finally, four o f the most isolated anti- 
mutagenic com fractions were analyzed by mass spectrometry. Matrix Assisted 
Laser Desorption/Ionization Mass Spectrometry (MALDI-MS) analyses showed the 
presence of molecules o f molecular fragments present in this fraction that have 
molecular masses between 250 and 640 m/z. Gas Chromatography Mass 
Spectrometry (GC-MS) detected one molecule or molecular fragment with that had
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93% similarity to linoleic acid (MW = 180). These results suggested the possibility 
that com components such as triglycerides and phospholipids (molecular mass 
ranging from 500 to 600 m/z) were detected by MALDI-MS. These molecules are 
formed from fatty acids such as linoleic, oleic, and stearic acids. The possibility that 
one of these molecules fragmented and were detected by the mass spectrometer was 
recognized. However, more specific studies are recommended to fully characterize 
the linoleic acid-like compound detected in one o f the anti-mutagenic com fractions.
Based on the results obtained from this project several studies are 
recommended to complement the information obtained: (1) the study of the study of 
the capability of other chemicals for improving ethanol production during the 
decontamination o f aflatoxin containing com by ammoniation, (2) a study of 
possible anti-mutagenic factors present in aqueous com extracts, (3) a study of the 
distribution and permanency of anti-mutagenic factors during processes applied to 
com, (4) a study of the stability o f these anti-mutagenic factors to different 
conditions, such as, pH, temperature, etc., and (5) a study of the protective effects of 
these anti-mutagenic com fractions in several in vivo systems. The information that 
can be obtained from these studies, in combination with that obtained from this 
project, might be o f great use to re-evaluate the potential risk associated with the 
consumption o f  aflatoxin-contaminated com.
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APPENDIX
Table A.l Mutagenic potential o f AFBi-contaminated- (AFB1-CC), AFBi-ffee- 
(AFB1-FC), and AFBi-spiked- (AFB1-SC) com in the Salmonella / microsomal 
mutagenicity assay using tester strains TA100 and TA98 with and without S9.































late 2 Plate 3 Mean SEM
55 49 56 5
78 60 63 8
67 57 62 3
53 61 58 2
63 68 73 8
74 66 70 2
67 60 62 2
68 68 69 1
17 28 35 13
46 64 52 6
56 70 53 11
52 78 62 8
57 57 60 3
51 58 56 3
12 60 39 14
38 60 48 6
68 64 71 5
57 60 57 1
67 50 63 7
50 62 62 7
53 60 49 8
69 88 77 6
59 52 53 3
78 69 77 4
Table continued
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Table continued
Sample/strain used Plate Plate 2 Plate 3 Mean SEM
TA100+S9
AFB1-FC 207 182 163 184 13
AFB1-FC (10E-1) 185 144 93 141 27
AFB1-FC (10E-2) 135 176 152 154 12
AFBl-FC(10E-3) 171 159 113 148 18
TA100-S9
AFB1-FC 248 261 268 259 6
AFB1-FC (10E-1) 234 241 296 257 20
AFB1-FC (10E-2) 271 269 212 251 19
AFBl-FC(10E-3) 293 225 246 255 20
TA100+S9
AFB1-SC 73 82 107 87 10
AFB1-SC (10E-1) 78 70 95 81 7
AFB1-SC (10E-2) 71 114 117 101 15
AFB1-SC (10E-3) 67 96 137 100 20
TA100-S9
AFB1-SC 250 230 229 236 7
AFB1-SC (10E-1) 261 212 219 231 15
AFB1-SC (10E-2) 273 241 239 251 11
AFB1-SC (10E-3) 214 244 190 216 16
TA100+S9
AFB1-CC 133 126 136 132 3
AFB1-CC (10E-1) 103 165 138 135 18
AFB1-CC (10E-2) 62 75 91 76 8
AFB1-CC (10E-3) 157 154 154 155 1
TA100-S9
AFB1-CC 154 138 157 150 6
AFB1-CC (10E-1) 157 150 189 165 12
AFB1-CC (10E-2) NA 169 192 180 60
AFB1-CC (10E-3) 203 NA 196 199 66
Natural revertants Plate 1 Plate 2 Plate 3 Mean SEM
TA 100+s9 129 146 141 139 5
TA 100-S9 320 275 219 271 29
TA 98 +S9 58 25 58 47 11
TA 98 -S9 71 70 58 66 4
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Table A.2.- Anti-mutagenic potential of AFBi-contaminated- (AFB1-CC) and A F B r 
free- (AFB1-FC) com in the Salmonella / microsomal mutagenicity assay using 
tester strains TA98 and TA100 with S9. Original extract was concentrated (5 and 25 
times) and diluted (5, 25, 125, and 625 times).
Sample (times diluted) Plate 1 Plate 2 Plate 3 MEAN SEN
TA100
AFB1-FC x(25) 130 128 148 135 6
AFB1-FC x(5) 150 179 164 164 8
AFB1-FC 494 404 406 434 30
AFB1-FC x(-5) 2000 2200 2184 2128 64
AFB1-FC x(-25) 998 1200 1170 1122 63
AFB1-FC x(-125) 2224 2844 2100 2389 230
AFB1-FC x(-625) 1014 872 1142 1009 78
AFB1-CC x(25) 129 121 114 121 4
AFB1-CC x(5) 145 121 134 133 7
AFB1-CC 231 223 213 222 5
AFB1-CC x(-5) 640 702 638 660 21
AFB1-CC x(-25) 890 640 630 720 85
AFB1-CC x(-125) 2600 2504 2692 2599 54
AFB1-CC x(-625) 2150 2148 2164 2154 5









42 48 41 4
44 57 54 5
116 143 123 10
616 676 685 42
406 540 509 53
1556 1510 1505 31
330 372 345 14
Table continued
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Table Continued
Sample (times diluted) Plate 1 Plate 2 Plate 3 MEAN SEM
AFB1-CC x(25) 29 34 48 37 6
AFB1-CC x(5) 30 47 25 34 7
AFB1-CC 80 49 59 63 9
AFB1-OC x(-5) 214 174 151 180 18
AFBl-CCx(-25) 175 160 156 164 6
AFB1-OC x(-125) 1130 1134 942 1069 63
AFBi-OC x(-625) 756 1074 809 880 98
Natural revertants 44 52 41 46 3
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Table A.3.- Anti-mutagenic potential of chromatographic regions Bl, B2, B3 
obtained form the TLC fractionation of AFBi-contaminated- (AFB1-CC) and AFBi- 
free- (AFB1-FC) com, and silica gel (S) in the Salmonella / microsomal mutagenicty 
assay, using tester strains TA98 and TA100 with S9. NA = not available.
Sample (times diluted) Plate 1 Plate 2 Plate 3 MEAN SEM
AFB1-CC
TA98
Bl 72 111 95 93 11
Blx(-5) 390 888 NA 639 257
Blx(-25) 358 231 301 297 37
Blx(-125) 480 524 454 486 20
Blx(-625) 586 NA NA 586 0
B2 40 49 56 48 5
B2x(-5) 149 144 127 140 7
B2x(-25) 246 204 272 241 20
B2x(-125) 289 494 466 416 64
B2x(-625) 610 410 NA 510 180
B3 95 90 90 92 2
B3x(-5) 110 116 88 105 9
B3x(-25) 359 404 379 381 13
B3x(-125) 227 295 235 252 21
B3x(-625) 193 494 458 382 95
AFB1-CC
TA100
Bl 820 560 574 651 84
Blx(-5) 1564 1628 2068 1753 158
Blx(-25) 1640 1572 1732 1648 46
Blx(-125) 1880 1900 2248 2009 119
Blx(-625) 1920 1896 1928 1915 10
Table continued
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Table continued 
Sample (times diluted) Plate 1 Plate 2 Plate 3 MEAN SEM
AFB1-CC
TA100
B2 183 210 196 196 8
B2x(-5) 1072 854 886 937 68
B2x(-25) 1920 1976 2020 1972 29
B2x(-125) 2508 2508 2508 2508 0
B2x(-625) 2520 2636 2380 2512 74
B3 164 162 175 167 4
B3x(-5) 836 544 620 667 87
B3x(-25) 2000 1844 2148 1997 88
B3x(-125) 1856 1936 1788 1860 43
B3x(-625) 2680 2648 2756 2695 32
AFB1-FC
TA98
Bl 160 153 202 172 15
Blx(-5) 1600 1700 1636 1645 29
Blx(-25) 2160 2068 2244 2157 51
Blx(-125) 1520 1628 1364 1504 77
Blx(-625) 2160 2292 2136 2196 48
B2 47 52 35 45 5
B2x(-5) 129 93 112 111 10
B2x(-25) 836 928 812 856 35
B2x(-125) 960 1064 1272 1099 92
B2x(-625) 1812 1932 1644 1796 83
B3 254 257 294 268 13
B3x(-5) 1448 1892 1788 1709 134
B3x(-25) 1408 1440 1472 1440 18
B3x(-125) 1728 1660 1624 1671 30
B3x(-625) 1408 1356 976 1247 136
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Table continued


























Plate 2 Plate 3 MEAN SEM
392 532 491 50
1920 2220 2107 94
2276 2152 2195 41
2328 2104 2237 86
2844 2460 2628 113
133 133 131 2
624 464 486 74
2212 2036 2116 51
2388 2212 2265 61
3336 3000 3152 98
680 554 621 37
3264 2520 2684 299
2328 2232 2308 39
2424 2248 2357 55
3432 2328 2920 321
1616 1748 1675 39
1400 1392 1419 23
658 1668 1234 300
2752 3060 2887 91
2940 3000 2944 31
2688 2640 2696 35
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Table continued
Sample (times diluted) Plate 1 Plate 2 Plate 3 MEAN SEM
TA98
AFBl(lOng) 78 58 59 65 6
AFBl(50ng) 157 282 297 245 44
AFBl(lOOng) 260 423 341 341 47
AFBl(500ng) 1368 1548 1040 1319 149
TA100
AFBl(lOng) 358 348 392 366 13
AFBl(50ng) 1100 870 990 987 66
AFBl(lOOng) 1812 1652 1600 1688 64
AFBl(500ng) 3396 2976 2964 3112 142
TA98
Nat.Rev. 29 24 38 30 4
DMSO 40 36 34 37 2
TA100
Nat.Rev. 180 155 163 166 7
DMSO 176 242 226 215 20
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Table A.4.- Anti-mutagenic potential o f chromatographic regions B2A, B2B, B2C, 
B2D, and B2E in the Salmonella / microsomal mutagenicity assay, using tester
strains TA98 and TA100 with S9.





























P la te  2 P la te  3 M EA N SEM
23 24 25 2
28 30 25 4
1348 1182 1243 53
2616 2688 2648 21
2916 2880 2912 17
1352 752 1085 176
174 188 187 7
2016 1860 1932 45
1440 1248 1296 73
684 936 807 73
508 612 607 55
664 580 615 25
208 255 214 22
2520 2904 2656 124
2748 1920 2276 246
1242 1224 967 266
880 802 841 22
60 47 56 5
764 880 815 34
1056 996 1024 17
948 1008 980 17
578 720 646 41
89 98 90 4
169 198 208 26
1836 1356 1544 148
1258 904 1087 102
1392 900 1363 259
Table continued
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Table continued
Region (times diluted) 
TA100
Plate 1 Plate 2 Plate 3 MEAN SEM
Nat.Rev. 166 161 156 161 3
DMSO 175 167 163 168 3
B2A 3168 3468 2928 3188 156
B2Ax(-5) 2640 2820 2496 2652 94
B2Ax(-25) 2520 2592 2364 2492 67
B2Ax(-125) 2340 2472 2220 2344 73
B2Ax(1625) 586 606 826 673 77
B2B 2280 2880 2988 2716 220
B2Bx(-5) 3120 3000 3648 3256 199
B2Bx(-25) 2592 2616 2580 2596 10
B2Bx(-125) 1800 1932 1728 1820 60
B2Bx(-625) 1632 3672 4284 3196 802
B2C 948 1024 1080 1017 38
B2Cx(-5) 3000 2856 2976 2944 44
B2Cx(-25) 3120 3444 3024 3196 127
B2Cx(-125) 2268 2016 2400 2228 113
B2Cx(-625 2200 1832 2240 2091 130
B2D 238 226 198 221 12
B2Dx(-5) 2928 2136 NA 2532 396
B2Dx(-25) 3180 3144 3120 3148 17
B2Dx(-125) 3720 3792 3744 3752 21
B2Dx(-625) 3040 3000 3152 3064 45
B2E 271 214 207 231 20
B2Ex(-5) 1008 1440 1220 1223 125
B2Ex(-25) 1932 2844 NA 2388 456
B2Ex(-125) 3008 2804 2868 2893 60
B2Ex(-625) 2676 2492 3088 2752 176
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Table A.5.- Anti-mutagenic potential o f regions B2E1, B2E2, B2E3, B2E4, B2E5,
and B2E6 in the Salmonella / microsomal mutagenicity assay, using tester strains
TA98 and TA100 with S9.
R e g i o n  ( t i m e s  d i l u t e d )
T A 9 8
P l a t e  1 P l a t e  2 P l a t e  3 M E A N S E M
N a t . R e v . 30 37 N A 33 1 1
B 2 E 1 3 0 4 4 3 6 3 5 8 3 6 6 38
B 2 E  l x ( - 5 ) 1 0 3 6 10 8 0 1 128 1081 27
B 2 E  l x ( - 2 5 ) 1 2 3 6 1 3 4 0 8 8 8 1155 137
B 2 E 1 x ( - l  2 5 ) 6 4 8 6 6 4 6 9 2 6 6 8 13
B 2 E 1 x ( - 6 2 5 ) 6 8 4 7 8 8 6 6 4 7 1 2 38
B 2 E 2 94 76 103 91 8
B 2 E 2 x ( - 5 ) 4 8 6 4 6 6 4 6 2 471 7
B 2 E 2 x ( - 2 5 ) 1 0 3 2 5 8 8 6 4 4 75 5 140
B 2 E 2 x ( - 1 2 5 ) 1 2 6 0 1 2 8 4 1 9 4 4 14 9 6 2 2 4
B 2 E 2 x ( - 6 2 5 ) 8 1 2 10 0 8 8 9 6 9 0 5 57
B 2 E 3 46 34 37 3 9 4
B 2 E 3 x ( - 5 ) 103 98 10 0 100 1
B 2 E 3 x ( - 2 5 ) 4 9 4 4 9 8 5 3 2 5 0 8 12
B 2 E 3 x ( - l  2 5 ) 6 6 8 7 5 6 7 9 6 7 4 0 38
B 2 E 3 x ( - 6 2 5 ) 9 3 2 11 5 2 9 2 4 1003 75
B 2 E 4 45 4 2 4 6 4 4 1
B 2 E 4 x ( - 5 ) 74 99 111 95 11
B 2 E 4 x ( - 2 5 ) 4 5 4 4 2 6 5 5 4 4 7 8 3 9
B 2 E 4 x ( - l  2 5 ) 7 7 6 7 6 0 9 7 2 8 3 6 68
B 2 E 4 x ( - 6 2 5 ) 4 0 2 39 3 5 1 8 4 3 8 4 0
B 2 E 5 4 7 2 3 8 0 4 2 8 4 2 7 27
B 2 E 5 x ( - 5 ) 7 9 6 1 0 7 4 1 2 7 4 1048 139
B 2 E 5 x ( - 2 5 ) 7 9 2 7 5 6 1 1 8 8 9 1 2 139
B 2 E 5 x ( - l  2 5 ) 5 2 0 5 4 0 5 0 0 5 2 0 1 1
B 2 E 5 x ( - 6 2 5 ) 4 0 8 3 8 4 3 8 4 3 9 2 8
B 2 E 6 2 6 2 2 8 0 3 6 8 3 0 3 33
B 2 E 6 x ( - 5 ) 5 8 6 6 2 8 6 7 6 6 3 0 2 6
B 2 E 6 x ( - 2 5 ) 6 5 2 13 3 2 1 0 0 0 9 9 5 196
B 2 E 6 x ( - l  2 5 ) 7 7 6 7 0 4 6 7 6 7 1 9 30
B 2 E 6 x ( - 6 2 5 ) 1 2 0 0 11 16 1 2 8 4 1 2 0 0 4 8
Table continued
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Table continued





B 2E lx(-5) 1392
B 2E lx(-25) 2520
B 2E lx(-125) 1668


























P la te  2 P la te  3 M EAN SEM
202 173 174 16
141 194 179 19
804 1028 855 89
1380 1404 1392 7
2808 1824 2384 292
1620 1716 1668 28
1872 1548 1696 95
271 285 305 27
1824 1620 1820 114
2352 3192 2688 257
3564 4272 3772 251
3468 3540 3556 56
196 163 169 14
345 302 339 20
2280 2148 2216 38
1488 1632 1560 42
3480 2388 3156 386
100 121 111 6
297 338 336 22
2484 2772 2540 121
4728 5016 4848 86
2844 2376 2620 135
2556 2512 2525 15
3468 3588 3512 38
2844 2808 2824 11
1656 3408 2224 592
3156 2136 2412 376
872 1014 899 60
1740 2340 1904 220
3312 2688 2984 181
2112 2412 2636 384
2748 3180 2896 142
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Table A.6.- Anti-mutagenic potential of bands B2E2A, B2E2B, B2E2C, and B2E2D
in the Salmonella /microsomal mutagenicity assay, using tester strains TA98 and
TA100 with S9, NA = Not available.
Band (times diluted) Plate 1 Plate 2 Plate 3 MEAN SEM
TA98
Nat.Rev. 31 33 38 34 2
DMSO 36 19 41 32 7
B2E2A 81 87 88 85 2
B2E2Ax(-5) 824 932 744 833 54
B2E2Ax(-25) 1236 1032 1212 1160 64
B2E2Ax(-125) 1008 1016 876 967 45
B2E2Ax(-625) 1080 1068 1032 1060 14
B2E2B 358 245 268 290 34
B2E2Bx(-5) 852 732 876 820 44
B2E2Bx(-25) 972 1044 792 936 75
B2E2Bx(-125) 984 984 744 904 80
B2E2Bx(-625) 840 812 768 807 21
B2E2C 410 450 792 551 121
B2E2Cx(-5) 1304 876 692 957 181
B2E2Cx(-25) 1296 1164 1248 1236 39
B2E2Cx(-125) 952 992 984 976 12
B2E2Cx(-625) 980 1032 960 991 21
B2E2Dx 328 390 458 392 37
B2E2Dx(-5) 910 958 964 944 17
B2E2Dx(-25) 1044 1104 984 1044 35
B2E2Dx(-125) 984 984 984 984 0
B2E2Dx(-625) 975 936 1152 1021 66
Table continued
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Table continued
Band (times diluted) 
TA100
Plate 1 Hate 2 Plate 3 MEAN SEM
Nat.Rev. 135 131 115 127 6
DMSO 115 151 156 141 13
B2E2A 538 780 418 579 106
B2E2Ax(-5) 1740 1704 1716 1720 11
B2E2Ax(-25) 2100 1992 2352 2148 107
B2E2Ax(-125) 2280 2148 1812 2080 139
B2E2Ax(-625) 2604 2592 2628 2608 11
B2E2B 1032 900 1152 1028 73
B2E2Bx(-5) 3132 3048 2916 3032 63
B2E2Bx(-25) 2568 2640 2508 2572 38
B2E2Bx(-125) 2940 3192 2772 2968 122
B2E2Bx(-625) 2544 2604 2448 2532 45
B2E2C 1704 NA NA 1704 0
B2E2Cx(-5) 3204 3180 3228 3204 14
B2E2Cx(-25) 2820 2844 2796 2820 14
B2E2Cx(-125) 2760 2628 2880 2756 73
B2E2Cx(-625) 3120 3648 3072 3280 184
B2E2Dx 1248 1236 1896 1460 218
B2E2Dx(-5) 3036 3012 3072 3040 17
B2E2Dx(-25) 3000 2976 3180 3052 64
B2E2Dx(-125) 3600 3696 3492 3596 59
B2E2Dx(-625) 3468 3360 3564 3464 59
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Table A.7.- Anti-mutagenic potential of bands B2E3A, B2E3B, and B2E3C in the
Salmonella / microsomal mutagenicity assay, using tester strains TA98 and TA100
with S9. Data for natural revertants are in Table A.6.
B a n d  ( t i m e s  d i l u t e d ) P l a t e  1
T A 9 8
B 2 E 3 A 776
B 2 E 3 A x ( - 5 ) 672
B 2 E 3  A x ( - 2 5 ) 708
B 2 E 3 A x ( - l  2 5 ) 828
B 2 E 3 A x ( - 6 2 5 ) 984
B 2 E 3 B 70
B 2 E 3 B  x ( - 5 ) 281
B 2 E 3 B  x ( - 2 5 ) 744
B 2 E 3 B  x ( - l  2 5 ) 960
B 2 E 3 B x ( - 6 2 5 ) 936
B 2 E 3 C 48
B 2 E 3 C x ( - 5 ) 366
B 2 E 3 C x ( - 2 5 ) 1080
B 2 E 3 C x ( - 1 2 5 ) 792
B 2 E 3 C x ( - 6 2 5 ) 852
T A 1 0 0
B 2 E 3 A 1416
B 2 E 3  A x ( - 5 ) 2 52 0
B 2 E 3  A x ( - 2 5 ) 2 940
B 2 E 3 A x ( - 1 2 5 ) 2 964
B 2 E 3 A x ( - 6 2 5 ) 2 280
B 2 E 3 B 137
B 2 E 3 B  x ( - 5 ) 950
B 2 E 3 B  x ( - 2 5 ) 3 000
B 2 E 3 B  x ( - l  2 5 ) 3 36 0
B 2 E 3 B  x ( - 6 2 5 ) 3 180
B 2 E 3 C 178
B 2 E 3 C  x ( - 5 ) 1800
B 2 E 3 C  x ( - 2 5 ) 3 36 0
B 2 E 3 C x ( - 1 2 5 ) 3192
B 2 E 3 C x ( - 6 2 5 ) 2 54 4
P l a t e  2 P l a t e  3 M E A N S E M
3 7 4 4 7 0 5 4 0 121
6 4 0 7 8 4 6 9 9 44
8 7 2 70 8 763 55
8 0 4 1 1 0 4 9 1 2 96
7 2 0 7 4 4 8 1 6 84
95 97 87 9
2 3 8 150 22 3 38
7 2 0 7 6 8 7 4 4 14
1 0 2 0 8 8 8 9 5 6 38
8 0 4 7 6 8 8 3 6 51
37 41 4 2 3
3 3 2 2 9 8 3 3 2 20
10 9 2 10 5 6 1076 11
6 9 6 10 5 6 8 4 8 108
8 0 4 9 5 4 8 7 0 4 4
1 7 7 6 2 4 1 2 1868 291
2 3 2 8 2 8 8 0 2 5 7 6 162
2 9 0 4 2 9 8 8 2 9 4 4 24
2 7 8 4 3 2 8 8 3 0 1 2 147
2 5 0 8 2 0 8 8 2 2 9 2 121
135 109 127 9
1 0 2 0 3 9 8 7 8 9 197
2 4 8 4 3 2 4 0 2 9 0 8 223
3 3 1 2 3 8 7 6 3 5 1 6 180
3 0 7 2 3 4 3 2 3 2 2 8 107
164 187 176 7
10 0 8 1128 1312 2 4 6
3 4 9 2 2 4 3 6 3 0 9 6 3 3 2
3 0 6 0 3 3 2 4 3 1 9 2 76
2 5 2 0 2 4 7 2 2 5 1 2 21
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Table A. 8.- Anti-mutagenic potential of band B2E4A in the Salmonella / microsomal
mutagenicity assay, using tester strains TA98 and TA100 with S9. Data for natural
revertants are in Table A.6.













Plate 2 Plate 3 MEAN SEM
35 51 47 6
89 91 97 7
580 720 641 41
1008 1224 1056 86
996 864 908 44
115 95 107 6
582 450 479 53
2832 2544 2672 85
3216 2976 3096 69
3240 3180 3180 35
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Table A.9.- Anti-mutagenic potential o f bands B2E2A1, B2E2A2, B2E3B1, 
B2E3B2, B2E3B3, B2E3B4, B2E3B5, B2E3B6, B2E3C1, B2E3C2, B2E3C3, 
B2E4A1, B2E4A2, B2E4A3, B2E4A4, B2E4A5, B2E4A6, in the Salmonella / 
microsomal mutagenicity assay, using tester strains TA98 and TA100 with S9.
Sample (times diluted) 
TA98
Plate 1 plate 2 Plate 3 MEAN SEM
Natural revertants 25 27 35 29 3
B2E2A1 2040 2880 1920 2280 302
B2E2Alx(-5) 1440 1872 1488 1600 137
B2E2Alx(-25) 756 768 780 768 7
B2E2Alx(-125) 1044 996 1164 1068 50
B2E2A2 1440 1728 1488 1552 89
B2E2A2x(-5) 1200 1332 1152 1228 54
B2E2A2x(-25) 732 1428 876 1012 212
B2E2A2x(-125) 1092 1320 888 1100 125
B2E3B1 2160 2160 2544 2288 128
B2E3Blx(-5) 780 720 864 788 42
B2E3Blx(-25) 696 696 456 616 80
B2E3Blx(-125) 780 744 816 780 21
B2E3B2 1584 1680 1380 1548 88
B2E3B2x(-5) 732 708 720 720 7
B2E3B2x(-25) 756 720 792 756 21
B2E3B2(-125) 840 852 840 844 4
B2E3B3 840 960 1236 1012 117
B2E3B3x(-5) 1152 756 720 876 138
B2E3B3x(-25) 516 612 560 563 28
B2E3B3x(-125) 1236 936 864 1012 114
B2E3B4 200 214 223 212 7
B2E3B4x(-5) 516 596 512 541 27
B2E3B4x(-25) 684 720 564 656 47
B2E3B4x(-125) 912 696 864 824 65
Table continued
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Table continued
Sample (times diluted) Plate 1 plate 2 Plate 3 MEAN SEM
B2E3B5 136 129 117 127 5
B2E3B5x(-5) 300 278 378 319 30
B2E3B5x(-25) 636 636 636 636 0
B2E3B5x(-125) 816 840 792 816 14
B2E3B6 1800 1800 1920 1840 40
B2E3B6x(-5) 1800 1800 1440 1680 120
B2E3B6x(-25) 1536 420 456 804 366
B2E3B6x(-125) 708 588 828 708 69
B2E3C1 1680 2016 1824 1840 97
B2E3Clx(-5) 720 756 684 720 21
B2E3Clx(-25) 780 744 876 800 39
B2E3Clx(-125) 840 828 876 848 14
B2E3C2 199 125 121 148 25
B2E3C2x(-5) 504 248 672 475 123
B2E3C2x(-25) 576 468 476 507 35
B2E3C2x(-125) 660 576 600 612 25
B2E3C3 21 29 29 26 3
B2E3C3x(-5) 194 184 230 203 14
B2E3C3x(-25) 352 342 348 347 3
B2E3C3x(-125) 792 780 472 681 105
B2E4A1 2160 1968 3792 2640 579
B2E4Alx(-5) 2160 1824 2784 2256 281
B2E4Alx(-25) 1140 1128 1140 1136 4
B2E4Alx(-125) 828 780 960 856 54
B2E4A2 1920 2160 1692 1924 135
B2E4A2x(-5) 1296 1344 1020 1220 101
B2E4A2x(-25) 1320 1200 1392 1304 56
B2E4A2x(-125) 1392 972 888 1084 156
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Table continued


















N a tu ra l re v e rta n ts 160
B2E2A1 322
B 2E 2A lx(-5) 3240
B 2E 2A lx(-25) 3228






B 2E 3B lx(-5) 2196
B2E3B lx (-2 5 ) 2880
B 2E 3B lx(-125) 2100
p la te  2 P la te  3 M EA N SEM
2532 2952 2636 161
2160 2052 2104 31
2064 1944 2008 35
2028 1248 1708 236
94 60 80 10
314 536 386 75
592 384 540 79
856 900 989 112
174 208 185 12
1344 792 1048 161
636 876 792 78
840 996 868 67
2016 2400 2112 147
1428 1812 1700 137
1272 960 1164 102
756 1272 956 160
111 138 136 14
408 536 422 62
3360 3156 3252 59
3228 2520 2992 236
3060 2844 2928 67
1872 2112 1992 69
2244 1272 1724 293
486 3060 1502 791
1100 640 953 156
868 1024 1319 375
1704 1002 1634 346
2796 3084 2920 85
2328 1932 2120 115
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Table continued
Sample (times diluted) Plate 1 plate 2 Plate 3 MEAN SEM
B2E3B2 2880 3360 3888 3376 291
B2E3B2x(-5) 1728 1788 1668 1728 35
B2E3B2x(-25) 2700 2784 2628 2704 45
B2E3B2(-125) 2520 2520 2736 2592 72
B2E3B3 1284 1236 1428 1316 58
B2E3B3x(-5) 3120 2904 3444 3156 157
B2E3B3x(-25) 3456 3408 3504 3456 28
B2E3B3x(-125) 3240 3168 3576 3328 126
B2E3B4 816 912 912 880 32
B2E3B4x(-5) 1992 2724 2052 2256 235
B2E3B4x(-25) 2904 3144 2808 2952 100
B2E3B4x(-125) 3000 2856 3288 3048 127
B2E3B5 644 676 564 628 33
B2E3B5x(-5) 1800 1896 1752 1816 42
B2E3B5x(-25) 3360 3540 3348 3416 62
B2E3B5x(-125) 3300 3504 2988 3264 150
B2E3B6 224 382 494 367 78
B2E3B6x(-5) 3360 3324 3636 3440 98
B2E3B6x(-25) 3168 3204 3120 3164 24
B2E3B6x(-125) 3228 3156 3300 3228 42
B2E3C1 72 202 870 381 247
B2E3Clx(-5) 3396 3516 3276 3396 69
B2E3Clx(-25) 3600 3432 4056 3696 186
B2E3Clx(-125) 3120 3000 2964 3028 47
B2E3C2 700 596 996 764 120
B2E3C2x(-5) 2016 2136 2448 2200 129
B2E3C2x(-25) 2784 3516 2124 2808 402
B2E3C2x(-125) 3660 3600 3708 3656 31
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Table continued
Sample (times diluted) Plate 1 plate 2 Plate 3 MEAN SEM
B2E3C3 101 128 126 118 9
B2E3C3x(-5) 924 1416 1068 1136 146
B2E3C3x(-25) 2880 2892 3192 2988 102
B2E3C3x(-125) 2940 3060 2616 2872 133
B2E4A1 688 484 314 495 108
B2E4Alx(-5) 2256 984 2004 1748 389
B2E4Alx(-25) 3600 3612 3624 3612 7
B2E4Alx(-125) 3204 3540 2916 3220 180
B2E4A2 204 770 1848 941 482
B2E4A2x(-5) 2940 3804 NA 3372 432
B2E4A2x(-25) 3624 3600 3660 3628 17
B2E4A2x(-125) 3264 3468 3060 3264 118
B2E4A3 600 655 204 486 142
B2E4A3x(-5) 284 496 1436 739 354
B2E4A3x(-25) 2556 2364 1956 2292 177
B2E4A3x(-125) 3072 3024 3168 3088 42
B2E4A4 277 179 193 216 31
B2E4A4x(-5) 1272 1296 1816 1461 177
B2E4A4x(-25) 2052 2052 2388 2164 112
B2E4A4x(-125) 3480 3480 3732 3564 84
B2E4A5 880 960 672 837 86
B2E4A5x(-5) 860 510 680 683 101
B2E4A5x(-25) 4068 4140 3960 4056 52
B2E4A5x(-125) 2784 3096 3816 3232 306
B2E4A6 1300 1370 1680 1450 117
B2E4A6x(-5) 1284 1740 404 1143 392
B2E4A6x(-25) 1452 1392 2616 1820 398
B2E4A6x(-125) 4248 3768 3228 3748 395
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Table A. 10.- Anti-mutagenic potential o f five different varieties of yellow com (#1,
#13, #28, #31, #32) in the Salmonella / microsomal mutagenicity assay, using tester
strains TA98 and TA100 with S9.





























Plate 2 Plate 3 MEAN SEM
36 29 38 6
26 27 27 0
61 67 66 2
492 368 415 39
1100 1018 1059 24
888 980 892 50
1264 1394 1323 38
67 60 64 2
203 252 206 25
524 884 583 159
1266 998 1088 89
1324 1352 1332 10
73 54 66 6
178 239 191 25
536 398 471 40
674 804 771 49
1270 1310 1307 20
71 62 68 3
173 168 164 6
376 380 389 11
808 834 821 7
1268 1132 1187 41
57 60 60 2
201 250 215 18
562 700 622 41
622 830 799 95
372 362 350 17
Table continued
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Table continued
Sample (times diluted) 
TA100
Plate 1 Plate 2 Plate 3 MEAN SEM
Nat.Rev. 196 203 124 174 25
DMSO 156 140 134 143 7
#1 139 143 145 142 2
#lx(-5) 1080 1044 1272 1132 71
#lx(-25) 1752 1676 1656 1695 29
#lx(-125) 1944 1908 2100 1984 59
#lx(-625) 2484 2604 2412 2500 56
#13 163 150 151 155 4
#13x(-5) 672 916 679 756 80
#13x(-25) 2280 2148 2412 2280 76
#13x(-125) 2832 2820 2868 2840 14
#13x(-625) 2568 2376 3396 2780 313
#28 186 189 182 186 2
#28x(-5) 728 648 804 727 45
#28x(-25) 1440 1560 1368 1456 56
#28x(-125) 2580 2460 2892 2644 129
#28x(-625) 2040 1896 2460 2132 169
#31 158 178 188 175 9
#31x(-5) 668 704 626 666 22
#31x(-25) 2040 2004 2124 2056 35
#31x(-125) 1600 1800 1536 1645 79
#31x(-625) 1704 1896 1776 1792 56
#32 193 202 158 184 13
#32x(-5) 876 844 860 860 9
#32x(-25) 2148 2136 2160 2148 7
#32x(-125) 1296 1260 1740 1432 154
#32x(-625) 1092 1092 1092 1092 0
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Table A .ll .-  Anti-mutagenic potential o f l-methyl-3-nitro-l-nitrosoguanidine 
(MNNG) and MNNG-spiked bands B2E2A, B2E3A, B2E3B, and B2E4A in the 
Salmonella /microsomal mutagenicity assay, using tester strain TA100 with and 
without S9.
S a m p l e ( t i m e s  d i l u t e d )  P l a t e  1 P l a t e  2  P l a t e  3  M E A N  S E M  
W i t h  S 9
N at.Rev. 181 156 168 168 7
DM SO 180 181 167 176 4
B2E2A 227 263 208 233 16
B2E2A x(-5) 339 333 244 305 31
B2E2A x(-25) 270 325 309 301 16
B2E2A x(-125) 232 317 249 266 26
B2E2A x(-625) 306 352 297 318 17
B2E3B 188 164 164 172 8
B 2E3B x(-5) 270 340 250 287 27
B2E3B x(-25) 324 324 308 319 5
B 2E3B x(-125) 310 294 324 309 9
B 2E3B x(-625) 332 306 294 311 11
B2E3C 113 151 123 129 11
B 2E3C x(-5) 222 181 150 184 21
B 2E3C x(-25) 300 234 384 306 43
B 2E3C x(-125) 338 310 227 292 33
B 2E3C x(-625) 238 366 302 302 37
B2E4A 103 128 117 116 7
B2E4A x(-5) 114 127 151 131 11
B 2E4A x(-25) 320 294 253 289 19
B 2E4A x(-125) 270 332 194 265 40
B 2E4A x(-625) 344 294 368 335 22
M N N G (l) 175 160 145 160 9
M N N G (50) 158 145 168 157 7
MNNG(IOO) 199 181 178 186 7
M N N G (250) 176 226 294 232 34
M N N G (500) 293 287 324 301 11
M N N G (900) 628 588 590 602 13
Table continued
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Plate 1 Plate 2 Plate 3 MEAN SEM
Nat.Rev. 131 133 165 143 11
DMSO 144 144 101 130 14
B2E2A 212 184 195 197 8
B2E2Ax(-5) 247 221 209 226 11
B2E2Ax(-25) 274 252 227 251 14
B2E2Ax(-125) 301 264 242 269 17
B2E2Ax(-625) 204 269 279 251 23
B2E3B 127 167 89 128 22
B2E3Bx(-5) 268 251 259 8
B2E3Bx(-25) 338 309 253 300 25
B2E3Bx(-125) 286 336 212 278 36
B2E3Bx(-625) 334 294 270 299 19
B2E3C 156 148 155 153 2
B2E3Cx(-5) 179 194 158 177 10
B2E3Cx(-25) 202 218 301 240 31
B2E3Cx(-125) 358 236 290 295 35
B2E3Cx(-625) 248 286 298 277 15
B2E4A 50 168 118 112 34
B2E4Ax(-5) 166 192 139 166 15
B2E4Ax(-25) 284 222 229 245 20
B2E4Ax(-125) 248 280 304 277 16
B2E4Ax(-625) 276 258 256 263 6
MNNG(l) 144 147 168 153 7
MNNG(50) 191 175 150 172 12
MNNG(IOO) 155 191 147 164 13
MNNG(250) 228 243 186 219 17
MNNG(500) 241 241 352 278 37
MNNG(900) 525 455 563 514 32
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Table A. 12.- Anti-mutagenic potential o f l-methyl-3-nitro-l-nitrosoguanidine
(MNNG)-spiked bands, B2E3A, B2E3B, and B2E4A in the Salmonella / microsomal
mutagenicity assay, using tester strain TA100 without S9.
Sample (times diluted) 
TA100
Plate 1 Plate 2 Plate 3 MEAN SEM
Nat. Rev. 117 145 128 130 8
DMSO 119 132 112 121 6
B2E3B 211 182 180 191 10
B2E3Bx(-5) 560 390 223 391 97
B2E3Bx(-25) 530 834 912 759 116
B2E3Bx(-125) 788 748 1160 899 131
B2E3Bx(-625) 1100 1500 1528 1376 138
B2E3C 271 272 174 239 32
B2E3Cx(-5) 468 732 587 596 76
B2E3Cx(-25) 862 538 890 763 113
B2E3Cx(-125) 880 620 2400 1300 555
B2E3Cx(-625) 832 954 788 858 50
B2E4A 1054 1056 394 835 220
B2E4Ax(-5) 960 1084 1324 1123 107
B2E4Ax(-25) 820 1058 896 925 70
B2E4Ax(-125) 1272 1176 852 1100 127
B2E4Ax(-625) 896 976 1094 989 57
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